ليست عنوان مقالات لاتين 1 - Experiences of an old-age psychiatric liaison service on a limited basis on a medical ward 10.6 μm Infrared light photoinduced insulator-to-metal transition in vanadium dioxide

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

1 - Experiences of an old-age psychiatric liaison service on a limited basis on a medical ward

2

1 + 1 > 2: Can this be true for dual isotope prostate brachytherapy?

3

1 Å crystal structures of B-DNA reveal sequence-specific binding and groove-specific bending of DNA by magnesium and calcium

4

1 Å crystal Structures of B-DNA reveal sequence-specific binding and groove-specific bending of DNA by magnesium and calcium

5

1- And 2-substituted naphthalenes: a new class of potential hypotensive agents

6

1 Atherosclerosis and the two faces of endothelial nitric oxide synthase (NOS III)

7

1 Differences in SLAP lesion between volleyball and baseball players

8

1 Direct and indirect effects of surgical tendon lengthening on muscle strength and gait parameters

9

1 Dynamic and passive analysis of anterior capsular contractures of the glenohumeral joint

10

1 f Type Fluctuations in One-dimensional Lennard–Jones Chain

11

1 GeV proton elastic scattering on 9Be nuclei in the a-cluster model with dispersion

12

1 GHz NMR spectroscopy: innovation in magnet technology

13

1 Gigabit/sec data recorder

14

1 hz rTMS over the right prefrontal cortex reduces vigilant attention to unmasked but not to masked fearful faces

15

1 kWe sodium borohydride hydrogen generation system: Part I: Experimental study

16

1 kWe sodium borohydride hydrogen generation system: Part II: Reactor modeling

17

1 min in the life of a river: selecting the optimal record length for the measurement of turbulence in fluvial boundary layers

18

1 Musculoskeletal ultrasound

19

1 MW and long pulse operation of Gaussian beam output gyrotron with CVD diamond window for fusion devices

20

1 mW CMOS polyphase channel filter for Bluetooth

21

1 MW gyrotron development for a large helical device

22

1 Primary breast cancer — is there a role for tumour markers?

23

1 The epidemiology of drug treatment failure in rheumatoid arthritis

24

1 The Impact of Distributed Energy Resources on the Reliability of Smart Distribution System

25

1 V 10 GHz CMOS frequency divider with low power consumption

26

1 V All-MOS ΣΔ A/D Converters in the Log-domain

27

1 V CMOS Subthreshold Log Domain PDM

28

1 V FM demodulator circuit

29

1 V fully balanced differential amplifiers: Implementation and experimental results

30

1 W fibre coupled power InGaAsP/InP 14xx pump laser for Raman amplification

31

1 year after The Lancet Neonatal Survival Series—was the call for action heard?

32

1- Actions of S on C0(X) and ideals of C0(X) ×α S

33

1- Effects of Salinity on Seedling Growth and Physiological Traits of Vetiver Grass (Vetiveria zizanioides Stapf)

34

1 1Bu–2 1Ag conical intersection in trans-butadiene: ultrafast dynamics and optical spectra

35

1 MeV electron irradiation influence on GaAs solar cell performance

36

1-((S)-γ-Substituted prolyl)-(S)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors

37

1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation

38

1-(1-Alkylsulfonic)-3-methylimidazolium chloride Brِnsted acidic ionic liquid catalyzed Skraup synthesis of quinolines under microwave heating

39

1-(1-Arylethylidene)thiosemicarbazide derivatives: A new class of tyrosinase inhibitors Original Research Article

40

1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands

41

1-(1-Propylsulfonic)-3-methylimidazolium chloride Brønsted acidic ionic liquid catalyzed one-pot synthesis of 14-aryl-14H-dibenzo[a,j]xanthene derivatives under solvent-free conditions

42

1-(2-((Z)-6-(2-(Trifluoromethyl)phenyl)hexa-3-en-1,5-diynyl)phenyl)piperidin-2-one as a new potent apoptosis agent Original Research Article

43

1-(2,3,4-Trihydroxybenzylideneamino)-8-hydroxynaphthalene-3,6-disulfonic acid as reagent for spectrophotometric determination of boron in plants

44

1-(2′-Aminophenyl)- and 1-(2′-hydroxyphenyl)-2-methyl-4-nitroimidazole: Crystallizing with two molecules in the asymmetric unit

45

1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands

46

1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2α: Synthesis, biological activity, metabolic stability, and solubility Original Research Article

47

1-(2-Formamidoethyl)-3-phenylurea functionalized activated carbon for selective solid-phase extraction and preconcentration of metal ions Original Research Article

48

1-(2-Iodophenyl)-1H-tetrazole as a ligand for Pd(II) catalyzed Heck reaction

49

1-(2-METHOXYPHENYL)-4-ALKYLPIPERAZINES: EFFECT OF THE N-4 SUBSTITUENT ON THE AFFINITY AND SELECTIVITY FOR DOPAMINE D4 RECEPTOR

50

1-(2-Methyl-5H-chromeno[2,3-b]pyridin-5-ylidene) hydrazone as fluorescent probes for selective zinc sensing in DMSO

51

1-(2-Naphthalenyl)benzimidazolium based fluorescent probe for acetate ion in 90% aqueous buffer

52

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 2: A survey of P4 motifs

53

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

54

1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity

55

1-(2-Pyridyl)-2-propen-1-ol: a multipurpose reagent in organic synthesis

56

1-(2-Quinolyl)-2-naphthol: A new intra-intermolecular photoacid–photobase molecule

57

1-(3-Deoxy-3-fluoro-β-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies Original Research Article

58

1-(3-Methoxycarbonyl)propyl-2-selenyl-[6,6]-methanofullerene as a n-Type Material for Organic Solar Cells

59

1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists

60

1-(4-Chlorophenyl)imidazole-2-thione (HtimAr) and its derivative tris(mercaptoimidazolyl)borate [BH(timAr)3]− of ruthenium complexes

61

1-(4-Dimethylaminobenzyl)-2-(4-dimethylaminophenyl)-benzimidazole: Synthesis, X-ray crystallography and density functional theory calculations

62

1-(4-Nitrophenoxycarbonyl)-7-pyridin-4-yl indolizine: a new versatile fluorescent building block. Application to the synthesis of a series of fluorescent β-cyclodextrins

63

1-(4-Nitrophenyl)-benzimidazolium-based ratiometric chromogenic probes for cyanide ion

64

1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues – Novel Inhibitors of Human Adenovirus Replication

65

1-(6-choloroquinoxaline-2-yl) Hydrazine as an Excellent Ionophore for Ppreparation of a Cobalt Selective Electrode and Potentiometric Measuring of Vitamin B12 in Pharmaceutical Samples

66

1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A2

67

1-(Arylsulfonyl)cyclopropanol, a new cyclopropanone equivalent and its application to prepare 1-alkynyl cyclopropylamine

68

1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT7 receptor ligands

69

1-(d-Glucopyranosyl-2′-deoxy-2′-iminomethyl)-2-hydroxybenzene as chemosensor for aromatic amino acids by switch-on fluorescence

70

1-(d-Glucopyranosyl-2′-deoxy-2′-iminomethyl)-2-hydroxynaphthalene as chemo-sensor for Fe3+ in aqueous HEPES buffer based on colour changes observable with the naked eye

71

1-(Dihydroxyphosphynyl)vinyl phosphate: The phosphonate analogue of phosphoenolpyruvate is a pH-dependent substrate of Kdo8P synthase

72

1-(Methyldithiocarbonyl)imidazole: a Useful Thiocarbonyl Transfer Reagent for Synthesis of Substituted Thioureas

73

1-(N-Acylamino)alkyltriphenylphosphonium salts as synthetic equivalents of N-acylimines and new effective α-amidoalkylating agents

74

1-(Naphthylamino)-1-(p-chlorophenylhydrazono)-2-propanone and 2-(p-tolyldiazenyl)-[1H]-3-methylbenzo[g]indole: Crystallographic and spectroscopic elucidation of the cyclisation of an arylamidrazone

75

1(phi) 3W grid-connection PV power inverter with partial active power filter

76

1-(Pyridin-2-ylmethyl)-2-(3-(1-(pyridin-2-ylmethyl)benzimidazol-2-yl) propyl) benzimidazole and its copper(II) complex as a new fluorescent sensor for dopamine (4-(2-aminoethyl)benzene-1,2-diol)

77

1(sigma)u+-X^1(sigma)g+ transition moments for the hydrogen molecule

78

1) Feeding a World Population of More Than Eight Billion People. A Challenge to Science: Edited by Waterlow J., Armstrong D., Fowden L. and Riley R., Oxford University Press, 1998, 280 pp. ISBN 0-19-511312-8

79

1, 2, 3 … FAIR ! Original Research Article

80

1, 2, 3, 4: Infusing Quantitative Literacy into Introductory Biology

81

1, 25 Dihydroxyvitamin D3 Protects the Heart Against Pressure Overload-induced Hypertrophy without Affecting SIRT1 mRNA Level

82

1, 25-Dihydroxyvitamin D3 level and lipids profile in some obese adults in Samarra city, Iraq

83

1, 25-dihydroxyvitamin D3, a potential role player in the development of thyroid disorders in schizophrenics

84

1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor Original Research Article

85

1, 4-diazabicyclo[2.2.2]octanium diacetate: an effective, mild and reusable catalyst for the synthesis of 2,4,5–trisubstituted imidazoles

86

1, 5-Bis (2-hydroxyacetophenone)thiocarbohydrazone: A novel colorimetric and fluorescent dual-mode chemosensor for the recognition of fluoride

87

1, 5-dicaffeoylquinic acid, an α-glucosidase inhibitor from the root of Dorema ammoniacum D. Don

88

1,1- and 1,3-Diiodo Neopentanes on Pt(111): Intermediates during Hydrocarbon Catalytic Conversion Reactions

89

1,1,1,2-Tetrafluoroethane; from refrigerant and propellant to solvent

90

1,1,1,3,3,3-hexafluoroisopropanol induced thermal unfolding and molten globule state of bovine (alpha)-lactalbumin: Calorimetric and spectroscopic studies

91

1,1,1,3-Tetrachloropropane

92

1,1,1-Trichloroethane-bound cytochrome P450cam dynamics. Does active site water make a difference? Original Research Article

93

1,1,2,2-Tetrafluoroethyl-N,N-dimethylamine: a new selective fluorinating agent

94

1,1,3,3,3-Pentafluoro-2-pentafluorophenyl-1,2-epoxypropane and trimethylphosphite: unusual 1,4-dioxan-2,5-dione ring formation

95

1,1,3,3,3-Pentafluoropropene secondary amine adducts new selective fluorinating agents

96

1,1,3,3-Tetraisopropyldisiloxane-1,3-diyl (TIPS) migration facilitates one-pot formation of enantiomerically pure methyl 2,3-epoxy-D-xylonate

97

1,1,3,3-Tetramethyl-1,3-disila-2-oxa[3]ferrocenophane: improved synthesis and new crystal structure

98

1,1′ Ferrocenylenediol as chelating ligand for cobalt in fivefold and sixfold coordination geometry: Synthesis, Electrochemistry and X-ray crystal structure of [{((1,1′ O2(η5-C5H5)2Fe)2}Co(OEt2){(η5-Me5C5)Co}2] and [{((1,1′ O2(η5-C5H5)2Fe)3}Co((η5-EtMe4C5

99

1,1′-(1-Propene-1,3-diyl)-ferrocene: modified synthesis, crystal structure, and polymerisation behaviour

100

1,1′-(Pyridine-2,6-diyl)bis(3-benzyl-2,3-dihydro-1H-imidazol-2-ylidene), a new multidentate N-heterocyclic biscarbene and its silver(I) complex derivative

101

1,1′,1′′-(2,4,6-Trihydroxybenzene-1,3,5-triyl)triethanone tautomerism revisited

102

1,1′,2,2′-Tetrakis(diphenylphosphino)-4,4′-di-tert-butylferrocene, a new cisoid arrangement of phosphino groups

103

1,1′-Binaphthyl ligands with bulky 3,3′-tertiaryalkyl substituents for the asymmetric alkyne addition to aromatic aldehydes

104

1,1′-Binaphthyl substituted calixresorcinols–methyl red complexes: receptors for optical saccharide sensing

105

1,1′-Binaphthyl subunits as recognition groups of novel macrocyclic ligands: Application for saccharide sensing

106

1,1′-Bis(3-hydroxypropyl)ferrocene: Preparation and substitution with polyfluoroalkyl groups

107

1,1′-Bis(diphenyloxophosphoryl)ferrocene (dpopf) as ligand in silver(I) complexes. Crystal structure of [Ag(dpopf)(PPh3)2]ClO4

108

1,1′-Bis(diphenylphosphino)ferrocene bridging two mono(cyclopentadienyl) cobalt moieties: Synthesis, structure, electrochemistry and DFT studies

109

1,1′-Bis(diphenylthiophosphoryl)ferrocene complexes of gold(I) and gold(III)

110

1,1′-Bis-(n-benzotriazolyl) ferrocenecarboxamide: Precursor for synthesis of 1,1′-bis-ferrocenoyl esters and thioesters

111

1,1′-Bis(oxazolinyl)ferrocene-based palladium catalysts: Synthesis, X-ray structures and applications in Suzuki and Heck coupling reactions

112

1,1′-Bis(phosphoranylidenamino)ferrocene palladium(II) complexes: An unusual case of dative Fe → Pd bonding

113

1,1′-Carbonyldiimidazole mediates the synthesis of N-substituted imidazole derivatives from Morita–Baylis–Hillman adducts

114

1,1′-Dicyano-2-substituted ethylenes: A new class of glucose uptake inhibitors in antifilarial chemotherapy

115

1,1′-Diethyl-2,2′,3,3′,4,4′,5,5′-octamethylferrocenium tetracyanoethylenide, [Fe(C5EtMe4)2]+[TCNE]−, a charge-transfer salt magnetic solid with a novel structural motif

116

1,1′-Ferrocene dicarboxylic acid pyridin-4-yl ester: A new bidentate ligand in arene ruthenium chemistry

117

1,1′-Ferrocenoyl–oligoprolines. A synthetic, structural and electrochemical study

118

1,1′-Methylene-bis(1,1′,2,2′,3,3′,4,4′-octahydroisoquinoline): synthesis, reaction, resolution, and application in catalytic enantioselective transformations

119

1,1′-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: A new potential copper chelator agent for neuroprotection in Alzheimer’s disease. Its comparative effects with clioquinol on rat brain copper distribution

120

1,10-Epoxyhypocretenolides from the Azorean Endemic Leontodon rigens (Asteraceae)

121

1,10-Phenanthroline as a complexing agent for on-line sorbent extraction/preconcentration for flow injection–flame atomic absorption spectrometry Original Research Article

122

1,10-Phenanthroline modified glassy carbon electrode for voltammetric determination of cadmium(II) ions

123

1,10-phenanthroline-5,6-dione adsorbed on carbon nanotubes: The electrochemistry and catalytic oxidation of ascorbic acid

124

1,10-Phenanthroline-5,6-dione as a building block for the synthesis of homo- and heterometallic complexes

125

1,10-Phenanthroline-5,6-dione complexes of middle transition elements: Mono- and dinuclear derivatives

126

1,10-Phenanthroline-dithiolate mixed ligand transition metal complexes. Synthesis, characterization and EPR spectroscopy

127

1,10-Phenanthrolinium ionic liquids exhibiting excellent solubility for metal complexes: Potential solvents for biphasic and supported ionic liquid phase (SILP) catalysis

128

1,12-Substituted tetracyclines as antioxidant agents Original Research Article

129

1,15-Bis-(2′,2′,4′-trimethyl-3′-pentoxy)phthalocyanine, a trans-form nonperipheral di-substituted phthalocyanine synthesized by the ‘cross condensation’ method

130

1,1-Azido bridge driven aggregation of a centrosymmetric trinuclear linear CoIIICoIICoIII complex

131

1,1-Bis(stannyl)- and 1,1-Bis(chlorostannyl)ferrocenes Studied by Multinuclear Magnetic Resonance, Temperature-Dependent 57Fe- and 119Sn-Mossbauer Spectroscopy, and Electrochemistry

132

1,1-Bis(trifluoromethyl)butadiene-1,3—A new fluorinated building block

133

1,1-Diamino-2-nitroethylenes as excellent hydrogen bond donor organocatalysts in the Michael addition of carbon-based nucleophiles to β-nitrostyrenes

134

1,1-dichloro-1-fluoroethane kills worker

135

1,1-Dihydroperoxycyclododecane as a new, crystalline non-hygroscopic oxidizer for the chemical synthesis of oligodeoxyribonucleotides

136

1,1-Dihydropolyfluoroalkylsulfides—versatile synthons in fluoroorganic chemistry

137

1,1-Dimethyl-4,4-bipyridinium-smectites as a novel adsorbent of phenols from water through chargetransfer interactions

138

1,1-Dimethylallylcoumarins potently supress both lipopolysaccharide- and interferon-γ-induced nitric oxide generation in mouse macrophage RAW 264.7 cells

139

1,1-Dimethylnaphthalenon-dimers as photocleavable linkers with improved two-photon-absorption efficiency and hydrolytic stability

140

1,1-Diphenyl-2-methylsulfinyl ethanol: a model compound to study the reactivity towards CNBr of a photoadduct of methionine on CγH2

141

1,1-Insertion of substituted alkynes into the Ir–O bond of η2-carboxylato iridium complexes

142

1,2- and 1,4-Naphthoquinones: general synthesis of benzo[b]naphtho[2,3-d]furan-6,11-diones

143

1,2- versus 1,3-Silyl migration in the reaction of acylsilanes with silyl-substituted carbanions

144

1,2,3,4,5,6-Hexahydrophosphinine 1-oxides with an exocyclic P-function at position 3: diastereoselective synthesis, stereostructure and conformation

145

1,2,3,4,5-Pentabromoferrocene and related compounds: A simple synthesis of useful precursors

146

1,2,3,4,6-Penta-O-galloyl-beta-d-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor

147

1,2,3,4-Tetrahydro-1,5-naphthyridines and related heterocyclic scaffolds: exploration of suitable chemistry for library development

148

1,2,3,4-tetrahydro-2-methyl-β-carboline and solavetivone from Solanum jabrense

149

1,2,3,4-Tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands

150

1,2,3,4-Tetrahydroisoquinoline Derivatives: A New Class of 5-HT1A Receptor Ligands Original Research Article

151

1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors

152

1,2,3,4-Tetrahydroquinoline-containing αVβ3 integrin antagonists with enhanced oral bioavailability

153

1,2,3,4-Tetrahydro-γ-carbolinium salts: novel reactions with thiols, mediated by polymer-supported reagents

154

1,2,3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation Original Research Article

155

1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors

156

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors

157

1,2,3-Triazol-1-imines. Part 3: Tandem 1,3 cycloaddition–rearrangement and open chain reactions of 2-aryl-N-aroyl-4,5-dimethyl-1,2,3-triazol-1-imines with dimethyl acetylenedicarboxylate

158

1,2,3-Triazol-5-ylidene–palladium complex catalyzed Mizoroki–Heck and Sonogashira coupling reactions

159

1,2,3-Triazole as a safer and practical substitute for cyanide in the Bruylants reaction for the synthesis of tertiary amines containing tertiary alkyl or aryl groups

160

1,2,3-Triazoles and related glycoconjugates as new glycosidase inhibitors

161

1,2,3-Triazoles as leaving groups in purine chemistry: a three-step synthesis of N6-substituted-2-triazolyl-adenine nucleosides and photophysical properties thereof

162

1,2,3-Triazolium-based poly(acrylate ionic liquid)s

163

1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors

164

1,2,3-Trisubstituted cyclohexyl substance P antagonists: significance of the ring nitrogen in piperidine-based NK-1 receptor antagonists

165

1,2,3-Trithiane-5-carboxylic acid, a first contact allergen from Asparagus officinalis (Liliaceae)

166

1,2,4,5-Tetra([5]trovacenyl)benzene: an organometallic tetraradical displaying pronounced electro- and magnetocommunication

167

1,2,4,5-Tetrazines as platform molecules for energetic materials and pharmaceuticals

168

1,2,4-Benzothiadiazine derivatives as α1 and 5-HT1A receptor ligands

169

1,2,4-Benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: Synthesis, DNA-binding affinity and cytotoxicity

170

1,2,4-Oxadiazoles from cycloreversions of oxadiazabicyclo[3.2.0]heptenes: 1-azetines as thiocyanate equivalents

171

1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2α inhibitors

172

1,2,4-Thiadiazole: A novel Cathepsin B inhibitor Original Research Article

173

1,2,4-Triacylpiperidine substance p antagonists: Separation of affinities for the NK-1 receptor and the L-type calcium channel

174

1,2,4-Triazine method of bipyridine ligand synthesis for the preparation of new luminescent Eu(III) complexes

175

1,2,4-Triazino-[5,6b]indole derivatives: effects of the trifluoromethyl group on in vitro antimalarial activity Original Research Article

176

1,2,4-Triazolato barium complex: The layered polymeric planar structure with an μ2-η2,η1 bridging coordination

177

1,2,4-Triazole and quinoxaline based polyimide reinforced with neat and epoxide-end capped modified SiC nanoparticles: Study thermal, mechanical and photophysical properties

178

1,2,4-Triazole-substituted metallophthalocyanines carrying redox active cobalt(II), manganese(III), titanium(IV) center and their electrochemical studies

179

1,2,4-Triazole-substituted metallophthalocyanines carrying redox active cobalt(II), manganese(III), titanium(IV) center and their electrochemical studies

180

1,2,4-Triazolium-5-ylidene and 1,2,4-triazol-3,5-diylidene as new ligands for transition metals

181

1,2,4-Triazolo mercapto and aminonitriles as potent antifungal agents

182

1,2,4-Triazolo[1,2-a]benzotriazoles: first examples of a novel ring system

183

1,2,4-Triazolo[3,4-a]pyridine as a novel, constrained template for fibrinogen receptor (GPIIb/IIIa) antagonists

184

1,2,4-triazolo[4,3-a]pyrimidines: a new kind of ligands. Structure of the silver(I) dimer with the 7-oxo derivative

185

1,2,4-Trichlorobenzene marine risk assessment with special emphasis on the Osparcom region North Sea

186

1,2,4-Trioxane in organic synthesis. Unusual entry to diverse carbocyclic frameworks derived from β-ionone

187

1,2,4-Triphospholyl gold(I) and copper(I) complexes: synthesis, crystal and molecular structures of [Cu(PMe3)2(μ-P3C2tBu2)(μ-I)Cu(PMe3)2], [Cu(PMe3)2(μ-P3C2tBu2)2Cu(PMe3)2] and [Au(η1-P3C2tBu2)2][Au(PEt3)2]

188

1,2,5,6-Tetra-O-benzyl- -mannitol derivatives as novel HIV protease inhibitors

189

1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors

190

1,2,5-Thiadiazolidin-3-one 1,1 Dioxide: A Powerful Scaffold for Probing the S′ Subsites of (Chymo)trypsin-Like Serine Proteases

191

1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase

192

1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation Original Research Article

193

1,2;3,4-Di-O-isopropylidene-l-galactose synthesis from its d-enantiomer

194

1,2′-Bis(4-aminophenoxy)benzene based designed fluoro-poly(ether-imide)/MMT clay nanocomposites: Synthesis and properties for high performance applications

195

1,24(S)-Dihydroxyvitamin D2, a biologically active analogue of vitamin D, is a naturally occurring metabolite in humans

196

1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D

197

1,25-Dihydroxyvitamin D3 and 9-cis-Retinoids Are Synergistic Regulators of 24-Hydroxylase Activity in the Rat and 1,25-Dihydroxyvitamin D3 Alters Retinoic Acid Metabolism in Vivo

198

1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage

199

1,25-dihydroxyvitamin D3 increases the activity of the intestinal sodium/calcium channel

200

1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro

201

1,25-Dihydroxyvitamin D3 inhibits secretion of interferon-γ by mitogen- and antigen-stimulated bovine mononuclear leukocytes

202

1,25-Dihydroxyvitamin D3 inhibits secretion of interferon-γ by mitogen- and antigen-stimulated bovine mononuclear leukocytes

203

1,25-Dihydroxyvitamin D3 Stimulates Vascular Endothelial Growth Factor Release in Aortic Smooth Muscle Cells: Role of p38 Mitogen-Activated Protein Kinase

204

1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation

205

1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization

206

1,25-Dihydroxyvitamin D3-induced HL-60 macrophages: regulation of cholesterol and LDL metabolism Original Research Article

207

1,2-Acyl group migration in the oxidative free radical reaction of 2-substituted-1,4-quinones

208

1,2-Asymmetric Induction in the Conjugate Addition of Organocopper Reagents to γ-Aryl α,β-Unsaturated Carbonyl Derivatives

209

1,2-Asymmetric induction in the ketene Claisen rearrangement of (2S,3E)-5-(isopropylsulfanyl)-3-pentenes

210

1,2-Azaboretidine formation in the reactions of (boryl)(silyl)iminomethanes via possible generation of (amino)(boryl)carbene species

211

1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors

212

1,2-Bis(2,5-diphenylphospholano)methane, a new ligand for asymmetric hydrogenation

213

1,2-Bis(diphenylphosphino)ethane nickel(II)dithiocarbamate as potential precursor for nickel sulfide: Effect of counter anion on phase and morphology

214

1,2-Bis[N-(N′-alkylimidazolium)]ethane salts as new guests for crown ethers and cryptands

215

1,2-Borotropic shifts and B–N bond cleavage reactions in molybdenum hydrotris(3-isopropylpyrazolyl)borate chemistry: Mixed-valence MoVIMo2V and pyrazole-rich oxo-MoIV complexes

216

1,2-Carbamoyl Migration on Enantio-enriched (alpha)-Lithioalkyl Carbamates Generated with s-Butyllithium/Sparteine: Steric Course and Mechanism

217

1,2-CF bond activation of perfluoroarenes and alkylidene isomers of titanium. DFT analysis of the C–F bond activation pathway and rotation of the titanium alkylidene moiety

218

1,2-Cis Selective Glycosylation with Glycosyl Fluoride by Using a Catalytic Amount of Trifluoromethanesulfonic Acid (TfOH) in the Coexistence of Molecular Sieve 5A (MS5A)

219

1,2-Cyclic sulfite and sulfate furanoside diesters: improved syntheses and stability

220

1,2-Dehydrogenation of steroidal 6-methylen derivatives. Synthesis of exemestane

221

1,2-diaminobenzimidazoles : Selective inhibitors of nitric oxide synthase derived from aminoguanidine

222

1,2-Diaryl-1-ethanone and pyrazolo [4,3-c] quinoline-4-one as novel selective cyclooxygenase-2 inhibitors

223

1,2-Dibromoalkanes into alkynes by elimination reaction under DBU conditions and their application to total synthesis of sapinofuranone B

224

1,2-Dibromotetrafluoroethane (Freon 114B2) as a building block for fluorine compounds

225

1,2-Dications in Organic Main Group Systems

226

1,2-Dichloroethane

227

1,2-Dihydro-2-thioxo-4H-3,1-benzothiazin-4-one: formation from carbon disulfide and isatoic anhydride

228

1,2-Dimethoxy-4,5-dimethylene: a new protecting group for acyclic amino acid derivatives prepared by Stevens rearrangement

229

1,2-Dimethylimidazole-4-sulfonyl chloride, a novel derivatization reagent for the analysis of phenolic compounds by liquid chromatography electrospray tandem mass spectrometry: Application to 1-hydroxypyrene in human urine

230

1,2-Di-O-acetyl-5-O-benzoyl-3-deoxy-l-erythro-pentofuranose, a convenient precursor for the stereospecific synthesis of nucleoside analogues with the unnatural β-l-configuration

231

1,2-Dioxo-3-isopropyloxy-4-methyl-3-cyclobutene as a nucleophilic synthon. Synthesis of Sq-containing cinnamic acid derivatives

232

1,2-Disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors

233

1,2-Disubstituted cyclohexane nucleosides: comparative study for the synthesis of cis and trans adenosine analogues

234

1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors

235

1,2-Dithiolate derivatives of monosilanes and disilanes

236

1,2-Ene dithiolate bridged diiron carbonyl-phosphine and -phosphite complexes in relevance to the active site of [FeFe]-hydrogenases: Synthesis, characterization and electrocatalysis

237

1,2-Ethanedisulfenyl chloride as a reagent for the preparation of ethylenedithio substituted aromatics

238

1,2-Ethylidene bridged bis-(benzimidazolyl, benzothiazolyl, and benzoxazolyl) transition metal complexes as catalysts for ethylene polymerization

239

1,2-GG intrastrand cross-link of antitumor dinuclear bifunctional platinum compound with spermidine linker inhibits DNA polymerization more effectively than the cross-link of conventional cisplatin

240

1,2-Metallate Rearrangements of (alpha)-Alkoxyalkyl Cuprates

241

1,2-O-(1-Ethylpropylidene)-α-d-glucofuranose, a low molecular mass organogelator: benzene gel formation and their thermal stabilities

242

1,2-Octanediol deracemization by stereoinversion using whole cells

243

1,2-O-Isopropylidene-5-alkene templates for the synthesis of oligo-tetrahydrofurans

244

1,2-O-Trichloroethylidene acetal group protected 3,5-dieno-1,4-furanose derivatives

245

1,2-oxazine linker as a thermal trigger for self-immolative polymers

246

1,2-Propanediol in strawberries and its role as a flavour precursor

247

1,2-rational N-soliton solutions for difference–differential equations related to the Volterra equation

248

1,2-Reduction of α,β-unsaturated hydrazones using dimethylamine–borane/p-toluenesulfonic acid: an easy route to allyl hydrazines

249

1,2-sn-Diacylglycerol in plant cells: Product, substrate and regulator

250

1,2-syn-Selective and Enantioselective Michael Reactions of Acyclic Enones with a Propionate-Derived Nucleophile Catalyzed by Oxazaborolidinone

251

1,2-trans-Glycosyl Azides of Sugar 2-Sulfonic Acids

252

1,3- and 1,4-Dithiane

253

1,3 Dichloro- and 1,3 dibromotetra-n-butyldistannoxane mixtures: ligand redistribution and fluxional dynamics in distannoxanes

254

1,3- versus 1,4-[π4+π2] Cycloadditions between methyl glyoxylate oxime and cyclopentadiene or cyclopentene

255

1,3- versus 1,4-Asymmetric induction in Mukaiyama–Michael additions of optically active ketene acetals to 2-methylcyclopent-2-en-1-one: a remarkable inversion of facial selectivity

256

1,3,2,4-Diazadiphosphetidines as new P–N ligands for palladium-catalyzed Heck reaction in water

257

1,3,2-Diazastanna-[3]ferrocenophanes bearing alkyn-1-yl groups at tin and their 1,1-organoboration with triethylborane—molecular structure of a novel spirotin compound

258

1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains

259

1,3,4-Oxadiazole formation; a novel solid support strategy

260

1,3,4-Oxadiazole-2(3H)-thione and its analogues: A new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors Original Research Article

261

1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: Synthesis, evaluation, and role of urea moiety Original Research Article

262

1,3,4-Thiadiazole rings as π-spacers in triphenylamine based dyes: A density functional theory study of reactivity, UV/Visible spectra, structural and optical properties

263

1,3,4-Thiadiazoles of pharmacological interest: Recent trends in their synthesis via tandem 1,3-dipolar cycloaddition: Review

264

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

265

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity

266

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activity

267

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV

268

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chains

269

1,3,5,7-Tetramethyl-8-aminozide-difluoroboradiaza-s-indacene as a new fluorescent labeling reagent for the determination of aliphatic aldehydes in serum with high performance liquid chromatography

270

1,3,5-Benzenetrisamide based nucleating agents for poly(vinylidene fluoride)

271

1,3,5-Cyclohexatriene captured in computro; the importance of resonance

272

1,3,5-Trialkyl-hexahydro-1,3,5-triazines–N-methylenealkylamines equilibria. 1H NMR studies in solutions

273

1,3,5-Triaryl-2-penten-1,5-dione anchored to insoluble supports as heterogeneous chromogenic chemosensor

274

1,3,5-Triaza-7-phosphaadamantane (PTA) ligated iridium(I) complexes as catalysts for the intramolecular hydroamination of 4-pentyn-1-amine in water

275

1,3,5-triazines inhibit osteosarcoma and avert lung metastasis in a patient-derived orthotopic xenograft mouse model with favorable pharmacokinetics

276

1,3,5-Triphosphabicyclo[3.1.0]hexene-(eta)3,(eta)1-diyl Hafnium Complexes: Structure and Reactivity

277

1,3,5-Tris(2-butyrylaminophenyl)benzene: a simple, acyclic chloride anion receptor

278

1,3,5-Trisubstituted aryls as highly selective PPARδ agonists

279

1,3,8,10-Tetrahydro-2,9-diazadibenzo[cd,lm]perylenes: synthesis of reduced perylene bisimide analogues

280

1,3:4,6-Di-O-benzylidene-d-mannitol as a source for novel chiral intermediates through regioselective reductive cleavage

281

1,3-Addition of silyl enol ethers to nitrones catalyzed by mesoporous aluminosilicate

282

1,3-Alternate 25,27-dibenzoiloxy-26,28-bis-[3-propyloxy]-calix[4]arene-bonded silica gel as a new type of HPLC stationary phase

283

1,3-Alternate calix[4]arene nitronyl nitroxide tetraradical and diradical: synthesis, X-ray crystallography, paramagnetic NMR spectroscopy, EPR spectroscopy, and magnetic studies

284

1,3-Benzodithiole-1,1,3,3-tetraoxide (BDT) as a versatile methylation reagent in catalytic enantioselective Michael addition reaction with enals

285

1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor

286

1,3-Bis(2,4,6-trimethylphenyl)imidazolium chloride in combination with triethylamine: an improved catalytic system for hydroacylation/reduction of activated ketones

287

1,3-Bis(3-ammonium-propyl)tetramethyldisiloxane-sulfate: Structural characterization and evaluation of some properties

288

1,3-Bis(3-hyroxymethyl-5-methyl-1-pyrazole) propane as corrosion inhibitor for steel in 0.5 M H2SO4 solution

289

1,3-Bis(4-methoxyphenyl)cyclohexane-1,3-diyl cation radical: divergent reactivity depending upon electron-transfer conditions

290

1,3-Bis(phenylmercapto)propane and 1-chloro-3-(phenylmercapto)propane: useful precursors for 1,3-dilithiopropane synthons in the preparation of 1,5-diols

291

1,3-Bis(α-aminoisopropyl)benzene, meta-C6H4(CMe2NH2)2: An N,N-bridging and N,C,N-cyclometalating ligand

292

1,3-Bis{(E)-[4-(dimethylamino)benzylidene]amino}propan-2-ol: chain structure formation via an O—H⋯N hydrogen bond

293

1,3-Butadiene Selective Oxidation over VMoO Catalysts: New Insights into the Reaction Pathway

294

1,3-Cycloaddition of nitrile oxides in ionic liquids. An easier route to 3-carboxy isoxazolines, potential constrained glutamic acid analogues

295

1,3-Cycloaddition of nitrones in ionic liquids catalyzed by Er(III): an easy access to isoxazolidines

296

1,3-Cycloaddition of pyrazole to the allenylidene ligand in [Re{C=C=CP(h)2}(CO)2{MeC(C(H)2PPh)2)3}]+

297

1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure–affinity and structure–selectivity relationships Original Research Article

298

1,3-Dialkylimidazolium-2-carboxylates as versatile N-heterocyclic carbene–CO2 adducts employed in the synthesis of carboxylates and α-alkylidene cyclic carbonates

299

1,3-Dialkylimidazolium-based room-temperature ionic liquids as background electrolyte and coating material in aqueous capillary electrophoresis

300

1,3-Diaminopropan-2-ol Sulfonamides as potent and selective inhibitors of the glycine transporter type 1

301

1,3-diaryl-2-carboxyindoles as potent non-peptide endothelin antagonists

302

1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2

303

1,3-Diarylimidazolidin-2-ylidene (NHC) complexes of Pd(II): Electronic effects on cross-coupling reactions and thermal decompositions

304

1,3-Diastereocontrol in acyclic radical allylations

305

1,3-Diazaphenalenes: a new donor system for hydrogen-bonded charge-transfer complexes

306

1,3-Diazolyl functionalized organopropylsilatranes: Synthesis and structural characterization

307

1,3-Dibenzylimidazolium salts: A paradigm of water and anion effect on the supramolecular H-bonds network

308

1,3-Diboraheterocycles as ligands in metal complexes involving endo-C–H bonds

309

1,3-Dibromo-5,5-dimethylhydantoin

310

1,3-Dibromo-5,5-dimethylhydantoin (DBH) as a cheap and efficient catalyst for the synthesis of polyhydroquinolines and 12-aryl-8,9,10,12-tetrahydro [a] xanthene-11-ones

311

1,3-Dibromo-5,5-dimethylhydantoin: a versatile catalyst for synthesis of 3,3-bis(indolyl)oxindoles

312

1,3-Dicarbonyl sugar derivatives from sugar nitro-olefins

313

1,3-Dichloro-2-butene: a useful precursor for the 2-butene-1,3-dianion and its corresponding 1,3-dipolar synthon

314

1,3-Dichloro-2-propanol induced hyperlipidemia in C57BL/6J mice via AMPK signaling pathway

315

1,3-Dichloro-2-propanol inhibits progesterone production through the expression of steroidogenic enzymes and cAMP concentration in Leydig cells

316

1,3-Dichloro-5,5-dimethyl hydantoin and Poly N,N′-dibromo-N- ethyl naphthyl-2,7-disulfonamide as efficient catalysts for the methoxymethylation of alcohols under solvent-free conditions

317

1,3-Dichloro-5,5-dimethylhydantoin: an efficient catalyst for the solvent free synthesis of 1,8-dioxo-octahydro-xanthenes

318

1,3-Dichloro-5,5-dimethylhydantoin: an efficient catalyst for the solvent free synthesis of 1,8-dioxo-octahydro-xanthenes

319

1,3-Dideoxynojirimycin-3-yl glycosides of β-(1→3)- and β-(1→6)-linked gluco-oligosaccharides Original Research Article

320

1,3-Dihalo-5,5-dimethylhydantoin/NaNO2 as an Efficient Heterogeneous System for the N-Nitrosation of N,N-Dialkylamines under Mild Conditions

321

1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptor

322

1,3-Dihydro-2,2-dioxothieno[3,4-c]pyridines as precursors for pyridine o-quinodimethane systems

323

1,3-Dihydrobenzo[c]furan nucleoside analogues: additional studies of the thymine derivative

324

1,3-Dilithio-2-(diphenylmethylene)propane

325

1,3-Dimethoxybenzene, a chemotaxonomic marker for the Neanurinae subfamily (Collembola)

326

1,3-Dimethyl-5-(3,4,5-tris(alkoxy)benzoyl) barbituric acid derivatives and their liquid crystalline difluoroboron complexes: Synthesis, characterization and comparative investigations of mesomorphic, thermotropic and thermo-morphologic properties

327

1,3-Dimethyl-7-substituted-1,2,3,4-tetrahydroisoquinolines as probes for the binding orientation of tetrahydroisoquinoline at the active site of phenylethanolamine N-methyltransferase Original Research Article

328

1,3-Dimethylimidazolium-2-carboxylate: the unexpected synthesis of an ionic liquid precursor and carbene-CO2 adduct

329

1,3-Dioxane-4,6-dione-5-carboxamide-based inhibitors of human group IIa phospholipase A2: X-ray structure of the complex and interfacial selection of inhibitors from a structural library

330

1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors

331

1,3-Dioxonium cation facilitated Ritter-type reaction: facile synthesis of protected aminopolyols

332

1,3-Diphosphapropenes for novel chemistry of metal complexes

333

1,3-Dipolar addition of diethyl diazomethylphosphonate onto a CN double bond. Synthesis of triazolinyl and aziridinyl phosphonates

334

1,3-Dipolar addition of nitrones to symmetrically substituted allenes: for the determination of absolute configuration of chiral allenes by NMR spectroscopy

335

1,3-Dipolar cycloaddition approach to isoxazole, isoxazoline and isoxazolidine analogues of C-nucleosides related to pseudouridine

336

1,3-Dipolar cycloaddition approach to pyrrolidine analogues of C-nucleosides related to pseudouridine

337

1,3-Dipolar cycloaddition of 1H-pyrazinium-3-olate and N1- and C-methyl substituted pyrazinium-3-olates with methyl acrylate: a density functional theory study

338

1,3-Dipolar cycloaddition of 2- and 3-nitroindoles with azomethine ylides. A new approach to pyrrolo[3,4-b]indoles

339

1,3-Dipolar cycloaddition of a chiral nitrone to (E)-1,4-dichloro-2-butene: a new efficient synthesis of (2S,3S,4R)-4-hydroxyisoleucine

340

1,3-Dipolar cycloaddition of alkynyliodonium salts with a nitrile oxide. Synthesis and reactivity of isoxazolyliodonium salts

341

1,3-Dipolar cycloaddition of arynes with azomethine imines: synthesis of 1,2-dihydropyrazolo[1,2-a]indazol-3(9H)-ones

342

1,3-Dipolar cycloaddition of azides with electron-deficient alkynes under mild condition in water

343

1,3-Dipolar cycloaddition of azomethine ylide with ethene and 2-butene: a computational study

344

1,3-Dipolar cycloaddition of azomethine ylides generated from aziridines in supercritical carbon dioxide

345

1,3-Dipolar cycloaddition of BC2N nanotubes: A DFT study

346

1,3-Dipolar Cycloaddition of Chirally Modified Vinylboronic Ester with Nitrile Oxides

347

1,3-Dipolar cycloaddition of diazoacetate compounds to terminal alkynes promoted by Zn(OTf)2: an efficient way to the preparation of pyrazoles

348

1,3-Dipolar cycloaddition of diazoalkanes onto dimethyl 1-(formylamino)ethylenephosphonate: a new route to 1-aminocyclopropanephosphonic acids and 3-phosphorylated pyrazoles

349

1,3-Dipolar cycloaddition of exo-methylenesugars with nitrone: approach to new amino-C-ketosyl disaccharides

350

1,3-Dipolar cycloaddition of N-[4-nitrophenyl]-C-[2-furyl] nitrilimine with some dipolarophiles: A combined experimental and theoretical study

351

1,3-Dipolar cycloaddition of nitrile imines with α,β-unsaturated lactones, thiolactones and lactams: synthesis of ring-fused pyrazoles

352

1,3-Dipolar cycloaddition of nitrile oxides to 1-phenylsulfonyl-1,3-butadienes: synthesis of 3-(4,5-dihydroisoxazol-5-yl)pyrroles

353

1,3-Dipolar cycloaddition of nitrile oxides to free and Pt-bound nitriles: a theoretical study of the activation effect, reactivity and mechanism

354

1,3-Dipolar cycloaddition of nitrile oxides with unsymmetrically substituted norbornenes

355

1,3-Dipolar cycloaddition of stabilised and non-stabilised azomethine ylides derived from uracil polyoxin C (UPoC): access to nikkomycin analogues

356

1,3-Dipolar cycloaddition of sugar azides with benzyne: a novel synthesis of 1,2,3-benzotriazolyl glycoconjugates Original Research Article

357

1,3-Dipolar cycloaddition of β-alkoxyvinyl trifluoromethylketones with aryl (or benzyl) azides: Synthesis of 4-trifluoroacetylated 1H-1,2,3-triazoles

358

1,3-Dipolar cycloaddition polymerization reactions of novel macromolecules containing sym-tetrazine rings

359

1,3-Dipolar cycloaddition reaction applied to synthesis of new unsymmetric liquid crystal compounds-based isoxazole

360

1,3-Dipolar cycloaddition reaction of [60]fullerene with thiocarbonyl ylide and synthetic application of the cycloadduct

361

1,3-Dipolar cycloaddition reaction of 3-trifluoromethyl-4-diazopyrazolinones with acetylenedicarboxylates

362

1,3-Dipolar Cycloaddition Reaction of Benzyl Azide with Cyclohex- 2-en-1-one. Experimental and Computational Study

363

1,3-Dipolar cycloaddition reaction of bipyridinium ylides with the propynamido-β-cyclodextrin. A regiospecific synthesis of a new class of fluorescent β-cyclodextrins

364

1,3-Dipolar Cycloaddition Reaction of Nitrile N-Oxides to 6-(2-Phenylethenyl)fulvene

365

1,3-Dipolar Cycloaddition Reaction of Nitrile Oxides to Isatin Imines

366

1,3-Dipolar cycloaddition reactions of benzo[b]thiophene 1,1-dioxide with azomethine ylides

367

1,3-Dipolar cycloaddition reactions of carbonyl ylides with 1,2-diones: synthesis of novel spiro oxabicycles

368

1,3-Dipolar cycloaddition reactions of ester-stabilized azomethine ylides with acrolein: a one-pot regio- and stereoselective synthesis of N-substituted 4-formyl-5-vinyl proline carboxylates

369

1,3-Dipolar cycloaddition reactions of ethyl 2-hydropoly(per)fluoroalk-2-enoates with nitrones

370

1,3-Dipolar Cycloaddition Reactions of N-Methyl-Substituted Tricyclic Imides

371

1,3-Dipolar Cycloaddition Reactions of Stable Bicyclic and Monocyclic Azomethine Ylides: Kinetic Aspects

372

1,3-Dipolar Cycloaddition Reactions of Stable Bicyclic and Monocyclic Azomethine Ylides: Preparative Aspects

373

1,3-Dipolar cycloaddition reactions on carbohydrate-based templates: synthesis of spiro-isoxazolines and 1,2,4-oxadiazoles as glycogen phosphorylase inhibitors

374

1,3-Dipolar cycloaddition route to novel isoxazole-type derivatives related to combretastatin A-4

375

1,3-Dipolar cycloaddition to the FeSC fragment 20. Preparation and properties of carbonyliron complexes of di-thiooxamide. Reactivity of the mononuclear (di-thiooxamide)Fe(CO)3 towards dimethyl acetylenedicarboxylate

376

1,3-Dipolar Cycloadditions of (4R*,5R*)-1-Arylmethylidene- 4-benzamido-3-oxo-5-phenylpyrazolidin-1-ium-2-ides to Di-(–)-menthyl Maleate

377

1,3-Dipolar cycloadditions of 2-thio-3-chloroacrylamides with nitrile oxides and nitrones

378

1,3-Dipolar cycloadditions of azomethine ylides to alkenylboronic esters. Access to substituted boron analogues of β-proline and 3-hydroxypyrrolidines

379

1,3-Dipolar cycloadditions of fluorinated nitrones with thioketones

380

1,3-Dipolar cycloadditions of MeOPEG-bounded azides

381

1,3-Dipolar cycloadditions of new 2,5-bifunctionalized five-membered cyclic nitrones

382

1,3-Dipolar cycloadditions of prop-1-ene-1,3-sultone with nitrile oxides/nitrones

383

1,3-Dipolar cycloadditions of silicon and tin alkynes and alkenes. Regiospecific synthesis of silyl and stannylpyrazoles and pyrazolines

384

1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists Original Research Article

385

1,3-Disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors

386

1,3-Disubstituted benzazepines as neuropeptide Y Y1 receptor antagonists Original Research Article

387

1,3-Disubstituted imidazolium hydroxides: Dry salts or wet carbenes?

388

1,3-Disubstituted-2-carboxy quinolones: highly potent and selective endothelin A receptor antagonists

389

1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors

390

1,3-Disulfonic acid imidazolium hydrogen sulfate {[Dsim]HSO4} as a highly efficient, recyclable and green catalyst for the preparation of α,α´- bis(arylidene)cycloalkanones

391

1,3-Disulfonic acid imidazolium hydrogen sulfate {[Dsim]HSO4} as a highly efficient, recyclable and green catalyst for the preparation of α,α´-bis(arylidene)cycloalkanones

392

1,3-Disulfonic Acid Imidazolium Trifluoroacetate as a Highly Efficient and Dual-Functional Catalyst for the Pseudo Five-Component Reaction of Phenylhydrazine with Ethyl Acetoacetate and Arylaldehydes

393

1,3-Dithian-2-ylidene and thiazolidin-2-ylidene derivatives as a novel class of antimycotic agents

394

1,3-Dithienylisothianaphthene derivatives as model compounds in the study of the electronic properties of poly(isothianaphthene) derivatives: an alternative synthesis

395

1,3-Dithiole-2-thione derivatives featuring an anthracene unit: new selective chemodosimeters for Hg(II) ion

396

1,3-Diyne chemistry: synthesis and derivations

397

1,3-Diynes synthesis by homo-coupling of terminal alkynes using a Pd(PPh3)4/Ag2O simple catalyst system

398

1,3-linked polyaromatics 1: Poly(pyrimid-4,6-diyl)s

399

1,3-linked polyaromatics 2: Poly(resorcin-4,6-diyl)s

400

1,3-linked polyaromatics 3: Extended diphenoquinones

401

1,3-Oxazoline- and 1,3-oxazolidine-2-thiones as substrates in direct modified Stille and Suzuki cross-coupling

402

1,3-Oxidative transpositions of allylic alcohols in organic synthesis

403

1,3-Phenyl linked urea-based receptors for anions and the facile cyclization to imidazolidinedione

404

1,3-Phosphorotropic migration in the C3NC5 triad of 1,4-benzodiazepines accompanied by isomerization of Ph2POC3NC5 to Ph2P(O)C5NC3

405

1,3-Polyol arrays via the stereoselective rearrangement of vinyl acetals

406

1,3-Propanediol production from glycerol with Lactobacillus diolivorans

407

1,3-Rearrangement of ketene-N,O-acetals

408

1,3-Sigmatropic fluorine migration to boron in McLafferty type of rearrangements: Observation of tetrafluorobenzyne radical cation and trifluorobenzyne cation by CID-mass spectrometry

409

1,3-Thiazino[6,5-b]indol-4-one derivatives. The first synthesis of indole phytoalexin cyclobrassinon

410

1,3-Thiazoline-2-thione-4,5-dithiolato, an efficient building block towards functionalized dithiadiazafulvalenes

411

1,3-β-D glucan binding protein (BGBP) from the white shrimp, Penaeus vannamei, is also a heparin binding protein

412

1,4 Additions with lithium bis(methylenecyclopropyl)cuprate

413

1,4,5-Trihydroxy-7-methoxy-9H-fluoren-9-one, a new cytotoxic compound from Dendrobium chrysotoxum

414

1,4,8,11-Tetraazacyclotetradecane bound to poly(p-chloromethylstyrene–ethylene glycol dimethacrylate) microbeads for selective gold uptake Original Research Article

415

1,4,9,10-Anthradiquinone as precursor for antitumor compounds Original Research Article

416

1,4-Addition of a Phosphinidene Complex to Cisoid 1,3-Dienes

417

1,4-Addition of an aryllithium reagent to diethyl ketomalonate. Scalable synthesis of ethyl 1-(hydroxymethyl)-1,3-dihydroisobenzofuran-1-carboxylate

418

1,4-Addition of aryl boronic acids to α,β-unsaturated ketones catalyzed by a CCC–NHC pincer rhodium complex

419

1,4-Addition of chiral 2-propenylphosphonamide anions to α-substituted cyclopentenones: use in enantioselective syntheses of methyl dihydrojasmonates and methyl jasmonates

420

1,4-Addition of tetraethyl fluoromethylenebisphosphonate to α,β-unsaturated compounds

421

1,4-Addition reaction of ethyl bromodifluoroacetate to Michael acceptors in the presence of copper powder: Improvement of the reaction using TMEDA as an additive

422

1,4-Additions of electron-rich heterocycles onto β-perfluoroalkyl enones

423

1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion

424

1,4-Aryl migration under copper(I) atom transfer conditions

425

1,4-Asymmetric induction in the titanium-mediated aldol reactions of α-benzyloxy methyl ketones

426

1,4-Benzodiazepin-2-one derived neurokinin-1 receptor antagonists

427

1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists

428

1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR

429

1,4-Benzoquinone Reductase from the BasidiomycetePhanerochaete chrysosporium:Spectral and Kinetic Analysis

430

1,4-Benzothiazine and 1,4-Benzoxazine imidazole derivatives with antifungal activity: A docking study Original Research Article

431

1,4-Bis-(2,3-epoxypropylamino)-9,10-anthracenedione and related compounds as potent antifungal and antimicrobial agents

432

1,4-Bis-(4-toluenesulphonyl)-1,4,7,10-tetraazacyclododecane from the direct tosylation of 1,4,7,10-tetraazacyclododecane

433

1,4-bis(5-decyl-2,2′-bithien-5-yl)benzene as new stable organic semiconductor for high performance thin film transistors

434

1,4-Bis(alkylamino)benzo[g]phthalazines able to form dinuclear complexes of Cu(II) which as free ligands behave as SOD inhibitors and show efficient in vitro activity against Trypanosoma cruzi Original Research Article

435

1,4-Bis(alkylsulfonyl)benzenes. A new and unexpected cathodic cleavage leading to the corresponding phenoxy ions

436

1,4-Bis(arylsulfonyl)-1,2,3,4-tetrahydropyridines in synthesis. Regio- and stereoselective SN1 reactions

437

1,4-Bis(arylsulfonyl)-1,2,3,4-tetrahydropyridines in Synthesis: Stereoselective Homo- and Hetero-Diels-Alder Reactions

438

1,4-Bis(arylsulfonyl)dihydropyridines in synthesis. Enantioselective synthesis of 2,3,6-trisubstituted piperidines

439

1,4-Bis(phosphine)-2,5-difluoro-3,6-dihydroxybenzenes and their P-oxides: Syntheses, structures, ligating and electronic properties

440

1,4-bis(triphenyl phosphonium)butane peroxodisulfate: conversion of alkyl benzenes to carbonyl compounds

441

1,4-bis[2,2-bis(trimethylsilyl)ethenyl]benzene: Regioselective ring opening of its α,β-epoxybis(silane) with some nucleophiles

442

1,4-Butanediyl dimethacrylate, a photoreactive diluent, synthesized via an unusual transesterification involving glycidyl methacrylate

443

1,4-Conjugate addition of allyltrimethylsilane to α,β-unsaturated ketones

444

1,4-Cycloaddition of pyrazole with mesityl oxide; solid-state structure of bicyclic [C6H5Me3N2(OH)]Cl

445

1,4-Cyclohexadiene with Pd/C as a rapid, safe transfer hydrogenation system with microwave heating

446

1,4-Cyclohexadienes as mechanistic probes for the Jacobsen epoxidation: evidence for radical pathways

447

1,4-Dehydrochlorination of 1-(1-haloalkyl)-3,4-dihydroisoquinolines as a convenient route to functionalized isoquinolines

448

1,4-Di(1,2,3,4-tetrazol-2-yl)butane as a precursor of new 2D and 3D coordination polymers of Cu(II)

449

1,4-Di(1,2,3-triazol-1-yl)butane as Building Block for the Preparation of the Iron(II) SpinCrossover 2D Coordination Polymer

450

1,4-Diamino-2-butanone, a putrescine analogue, promotes redox imbalance in Trypanosoma cruzi and mammalian cells

451

1,4-Diaryl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acids as endothelin receptor antagonists

452

1,4-Diaza-1,3-diene (DAD) complexes of early transition elements. Syntheses, structures and molecular dynamics of mono- and bis(η5-cyclopentadienyl)titanium-, zirconium- and hafnium(DAD) complexes. Crystal- and molecular structures of CpTi(DAD)CH2Ph, [CpT

453

1,4-Diaza-1,3-diene (DAD) complexes of early transition metals. Synthesis and structural characterization of (t-Bu-DAD)ZrCl(μ-Cl)3Zr(t-Bu-DAD)(THF) and its reaction with benzophenone

454

1,4-Diazabicyclo[2.2.2]octane 1,4-Bis(oxide)-Bis(hydrogen peroxide)/MClx as a Novel Heterogeneous System for the Oxidation of Urazoles under Mild Conditions

455

1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1

456

1,4-Diazepane-2-ones as novel inhibitors of LFA-1

457

1,4-Dibenzylpiperazines possess anticocaine activity

458

1,4-Dibutoxy-2,3-di(4-pyridyl)-8,11,15,18,22,25-hexakis(hexyl)phthalocyaninato zinc, a self-assembled coordination polymer in the solid state

459

1,4-Dihydro-2,3-quinoxalinediones as potential flavin metabolites and excitatory amino acid receptor ligands. Part 1: Synthesis and pharmacological evaluation of the benzylic oxidation series of 1,4-dihydro-6,7-dimethyl-2,3-quinoxalinedione Original Resea

460

1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors

461

1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Extended exploration on phenyl ring substitutions and preliminary ADME/PK studies

462

1,4-Dihydro-l-phenylalanine—Its Synthesis and Behavior in the Phenylalanine Ammonia–Lyase Reaction

463

1,4-Dihydropicolinic acid derivatives: novel NADH analogues with an altered connectivity pattern

464

1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety Original Research Article

465

1,4-Dihydropyridine equivalents: a novel approach to 2,6-dicyanopiperidine derivatives

466

1,4-Dihydropyridines bearing a pharmacophoric fragment of lidoflazine Original Research Article

467

1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.04,9]tetradecane and Derivatives with In vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum

468

1,4-Dihydroxyxanthone modulates the adhesive property of endothelial cells by inhibiting intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin Original Research Article

469

1,4-Diionic organophosphorus compounds: Stereoselective synthesis of dialkyl 2-(1,1,1,5,5,5-hexafluoro-2,4-dioxo-pentane-3-yl-3-yide)-3-triphenylphosphoniobutane-1,4-dioates

470

1,4-Dioxane-2,5-dione-type monomers derived from l-ascorbic and d-isoascorbic acids. Synthesis and polymerisation

471

1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)

472

1,4-Disulfopiperazine-1,4-diium chloride ([Piper-(SO3H)2].2Cl) as an efficient ionic catalyst for synthesis of phthalazine derivatives

473

1,4-Dithiane-2,5-diol as an efficient synthon for a straightforward synthesis of functionalized tetrahydrothiophenes via sulfa-Michael/aldol-type reactions with electrophilic alkenes

474

1,4-Diynes from alkynyl–propargyl coupling reactions

475

1,4-Elimination/Brønsted acid catalyzed aza-Ferrier reaction sequence as an entry to β-amino-β,γ-unsaturated aldehydes

476

1,4-Induction in aldol reactions of (tertiary α′-alkoxy)methyl ketones: synthesis of the C8–C11 stereotriad of ent-fostriecin

477

1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis

478

1,4-Naphthoquinones as inducers of oxidative damage and stress signaling in HaCaT human keratinocytes

479

1,4-Phenylene-bridged meso–meso linked diporphyrin array

480

1,4-Phenylene-di(N-l-alanylaminomethylphosphonate) a new diaminophosphonate peptide receptor for lysine and arginine

481

1,4-syn-Asymmetric induction in the titanium-mediated aldol reactions of chiral methyl α-silyloxy ketones

482

1,4-Zwitterionic intermediates formed by cleavage of a cyclobutane ring and their cycloaddition reactions

483

1,5,7-Triazabicyclo[4.4.0]dec-1-ene (TBD), 7-methyl-TBD (MTBD) and the polymer-supported TBD (P-TBD): three efficient catalysts for the nitroaldol (Henry) reaction and for the addition of dialkyl phosphites to unsaturated systems

484

1,5,7-Triazabicyclo[4.4.0]dec-5-ene (TBD) an efficient homogeneous catalyst for aldol condensation reactions. Study of the catalyst recovery and reusability using CO2

485

1,5,7-Triazabicyclo[4.4.0]dec-5-ene (TBD) catalyzed Michael reactions

486

1,5-Anhydro-d-fructose from d-fructose

487

1,5-Anhydro-d-fructose: biocatalytic and chemical synthetic methods for the preparation, transformation and derivatization Review Article

488

1,5-Anhydro-d-fructose: regioselective acylation with fatty acids

489

1,5-Anhydro-d-fructose; a versatile chiral building block: biochemistry and chemistry Review Article

490

1,5-Anhydroxylitol from leaves of Olea europaea

491

1,5-Benzodiazepines as CCK-B antagonists. Effect of halogen substitution at the benzo-fused ring on potency and selectivity

492

1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists

493

1,5-Benzoheteroazepines through eco-friendly general condensation reactions

494

1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives

495

1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives

496

1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5′-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators

497

1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin Original Research Article

498

1,5-Disubstituted imidazoles inhibit juvenile hormone biosynthesis by the corpora allata of the mosquito Aedes aegypti

499

1,5-Electrocyclisation of azomethine ylides leading to pyrrolo[2,1-a]isoquinolines—concise construction of the lamellarin skeleton

500

1,5-Hydrogen atom transfer/radical cyclization of cycloalkanones bearing a β-iodo α,β-unsaturated ester or nitrile side chain

501

1,5-hydrogen transfer — a hitherto ignored decay channel in the photodegradation of poly(2,6-dimethyl-1,4-phenylene oxide)

502

1,5-Remote stereocontrol using allylgermanes

503

1,5-Stereocontrol in reactions of 5-benzyloxy-4-methylpent-2-enyl bromides with aldehydes mediated by Bi(0): synthesis of aliphatic compounds with 1,5-syn-related methyl groups

504

1,5-Stereocontrol in tin(IV) halide mediated reactions between N- and S-substituted pent-2-enylstannanes and aldehydes or imines

505

1,5-Stereocontrol in tin(IV) halide promoted reactions of 2-alkoxy-1-(2-tributylstannylethylidene)cyclohexanes with aldehydes

506

1,5-Type nonbonded O⋯S and S⋯S interactions in (acylimino) and (thioacylimino)benzothiazoline systems. Crystal structures and theoretical calculations

507

1,6- and 1,7-regioisomers of dinitro- and diamino-substituted perylene bisimides: synthesis, photophysical and electrochemical properties

508

1,6-Anhydro-β-l-hexopyranoses as valuable building blocks toward the synthesis of l-gulosamine and l-altrose derivatives

509

1,6-Bis(4-methoxyphenylsulfanyl) perchlorofluoranthene: A molecule with sandwiched π–π stacking linked by a flexible five-membered ring

510

1,6-CH insertion of alkylidenecarbenes in 1-naphthol and 1-anthrol derivatives

511

1,6-Diaminohexane contributes to the hexamethylene bisacetamide-induced erythroid differentiation pathway by stimulating Ca2+ release from inositol 1,4,5-trisphosphate-sensitive stores and promoting Ca2+ influx

512

1,6-Dibenzylglycoluril for synthesis of deprotected glycoluril dimer

513

1,6-Disubstituted perylene bisimides: concise synthesis and characterization as near-infrared fluorescent dyes

514

1,6-Remote stereocontrol using allylgermanes

515

1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors

516

1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors

517

1,7-Dinitroperylene bisimides: facile synthesis and characterization as n-type organic semiconductors

518

1,7-Electrocyclisations of stabilised azomethine ylides

519

1,8,10,17-Tetraazapentacyclo[8.8.1.18,17.02,7.011,16]icosane X-ray crystal structure revisited

520

1,8-Anthrancene disulfonamide: A simple but highly sensitive and selective fluorescent chemosensor for Hg2+ in aqueous media

521

1,8-Bis(dimethylamino)-2-(4-methoxyphenyl)naphthalene: An electrospray-active analogue for η6-coordinating ligands

522

1,8-Bis(dimethylamino)naphthalene/9-aminoacridine: A new binary matrix for lipid fingerprinting of intact bacteria by matrix assisted laser desorption ionization mass spectrometry Original Research Article

523

1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis

524

1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) as ligand for atom transfer radical polymerization (ATRP)

525

1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU)-promoted efficient and versatile aza-Michael addition

526

1,8-Dihydroxyanthraquinone anchored on silica gel: synthesis and application as solid phase extractant for lead(II), zinc(II) and cadmium(II) prior to their determination by flame atomic absorption spectrometry

527

1,8-Dihydroxyanthraquinone anchored on silica gel: synthesis and application as solid phase extractant for lead(II), zinc(II) and cadmium(II) prior to their determination by flame atomic absorption spectrometry

528

1,8-Naphthalimide-based ‘turn-on’ fluorescent sensor for the detection of zinc ion in aqueous media and its applications for bioimaging

529

1,8-Naphthalimide-based colorimetric and fluorescent sensor for recognition of GMP, TMP, and UMP and its application in in vivo imaging

530

1,8-Naphthalimide-based visible colorimetric sensor for the selective sensing of fluoride, acetate and hydroxyl anions

531

1,8-Naphthalimides for non-doping OLEDs: the tunable emission color from blue, green to red

532

1,8-Naphthyridin-2,7-(1,8H)-dione is an effective mimic of protonated cytosine in peptide nucleic acid triplex recognition systems

533

1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors

534

1,8-Naphthyridine modified rhodamine B derivative and Cu2+ complex: colorimetric sensing of thiols in aqueous media

535

1,9-Bis(N,N-dimethylaminomethyl)dipyrromethanes in the synthesis of porphyrins bearing one or two meso substituents

536

1,n′-Disubstituted ferrocenoyl amino acids and dipeptides: Conformational analysis by CD spectroscopy, X-ray crystallography, and DFT calculations

537

1,N6-Etheno-2′-deoxytubercidin and pyrrolo-C: synthesis, base pairing, and fluorescence properties of 7-deazapurine nucleosides and oligonucleotides

538

1,n-Diamines. Part 2: Synthesis of acyclic and heterocyclic N-arylputrescine derivatives

539

1,n-Diamines. Part 3: Microwave-assisted synthesis of N-acyl-N′-arylhexahydropyrimidines and hexahydro-1,3-diazepines

540

1,n-Diamines. Part 4: synthesis of 1-aryl-2-alkyl-1,4,5,6,7,8-hexahydro-1,3-diazocines

541

1. A review of the impact of pre-operative education on recovery from surgery

542

1. Arimidex: profile of a potent, selective, orally active aromatase inhibitor

543

1. Asia as the center of gravity of the world energy system

544

1. Carbon Tetrachloride,: Environmental Health Criteria, No. 208, 1999, xviii+177 pages (English with summaries in French and Spanish), ISBN 92 4 157208 6; Sw.fr. 42.-/US $37.80; in developing countries: Sw.fr. 29.40. Order no. 1160208; WHO, 1211 Geneva 2

545

1. Commentary on Feasibility study for image-guided kidney surgery: assessment of required intraoperative surface for accurate physical to image space registrations: Benincasa AB, Clements LW, Herrell SD, Galloway RL, Department of Biomedical Engineering,

546

1. Commentary on Mortality results from a randomized prostate-cancer screening trial: Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, OʹBrien B, Clapp JD, Rathmell JM

547

1. Effect of L-Arginine Modified Magnetic Nanoparticles (RMNPs) on Lysozyme in the Presence or Absence of Urea

548

1. Endothelin antagonists: Search for surrogates of methylendioxyphenyl by means of a kohonen neural network

549

1. Field and Laboratory Studies of Acid Sulfate Soils

550

1. Linking heart failure and sleep medicine: An integrative team for the management of sleep-disordered breathing in heart failure

551

1. Microvascular tumor invasion in renal cell carcinoma: The most important prognostic factor: Dall’Oglio MF, Antunes AA, Sarkis AS, Crippa A, Leite KR, Lucon AM, Srougi M, Division of Urology, University of Sao Paulo Medical School, Sao Paulo, Brazil

552

1. NEW LIFE PATTERNS AND CHANGING GENDER ROLES

553

1. Physical activity and exercise nonadherence in heart failure: Understanding interrelationships between knowledge, emotions, time and desire

554

1. Pre-movement gating of the somatosensory-evoked potentials recorded from the human thalamus

555

1. Prognostic and predictive factors for early breast cancer

556

1. Prostate cancer-specific survival following salvage radiotherapy vs. observation in men with biochemical recurrence after radical prostatectomy: Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC, Brady Urological Institute, J

557

1. Redefining pT3 renal cell carcinoma in the modern era: A proposal for a revision of the current TNM primary tumor classification system: Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG, Department of Urology, The University of Texas, M.

558

1. Role of HDL in reverse cholesterol transport

559

1. Salt-HF: Sodium and liquids and time to rehospitalization-heart Failure

560

1. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer: Li G, Feng G, Gentil-Perret A, Genin C, Tostain J, Department of Urology, North Hospital, CHU of Saint-Etienne, Saint-Etienne, France

561

1. Sorafenib in advanced clear-cell renal-cell carcinoma: Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukow

562

1. Studies in the quality of life in childhood epilepsy: Materials, methods, “mea culpa”

563

1. Temporal coupling of brain oscillations during REM sleep: Reorganization by phasic activity and functional implications

564

1. The Effect of implementing a standardized heart failure education plan on nurse perception of competency and adequacy

565

1. The genesis of World Patent Information and its aims

566

1. The Monetary Policy, Credit Constraint and Spatial Distribution of Economic Activity: A Contribution of New Economic Geography

567

1. Transcranial magnetic stimulation in differential diagnosis of epilepsy and psychogenic non-epileptic seizures

568

1. Use of a novel laboratory stream system to study the ecological impact of PCB exposure in a periphytic biolayer

569

1. The ichthyofauna of headwaters of three riverine systems in Kohgiluyeh and Boyer-Ahmad Province in southwest of Iran

570

1.06 μm laser transition characteristics of Nd3+-doped fluorophosphate glasses

571

1.1 The coupling between optical flow and neonatal stepping

572

1.1 V full-swing double bootstrapped BiCMOS logic gates

573

1.1 V Low-Power ΣΔ Modulator for 14-bit, 16 KHz A/D Conversion Using a New Low-Voltage Class-AB Op-amp

574

1.1 μm superficially porous particles for liquid chromatography. Part I: Synthesis and particle structure characterization

575

1.1. Brain stem control of eye movements

576

1.10 Maturation of dynamic balance

577

1.11 Learning to walk modifies the whole locomotor skeleton. Functional meaning of these changes for posture and gait

578

1.12 What visual information guides navigation aroundobstacles in children?

579

1.13 Posture stability perfection and spectrum EEG mapping changes during gymnastics training in girls 4–7 vears

580

1.14 Attention demands of postural control in typicallydeveloping children

581

1.2 Å Crystal Structure of the Serine Carboxyl Proteinase Pro-Kumamolisin: Structure of an Intact Pro-Subtilase

582

1.2 Multiple obstacle avoidance strategies in adults and mid-childhood aged children

583

1.2. 3-D brainstem mapping

584

1.25 Å Resolution Crystal Structures of Human Haemoglobin in the Oxy, Deoxy and Carbonmonoxy Forms

585

1.3 (mu)m double quantum well GaInNAs distributed feedback laser diode with 13.8 GHz small signal modulation bandwidth

586

1.3 (mu)m GaAs/GaAsSb quantum well laser grown by solid source molecular beam epitaxy

587

1.3 (mu)m InAs/GaAs multilayer quantum-dot laser with extremely low room-temperature threshold current density

588

1.3 Å Structure of Arylsulfatase from Pseudomonas aeruginosa Establishes the Catalytic Mechanism of Sulfate Ester Cleavage in the Sulfatase Family

589

1.3 Billion years of acritarch history: An empirical morphospace approach

590

1.3 Gait kinematics in newly walking toddlers

591

1.3 V supply voltage 38 GHz static frequency divider

592

1.3 μm electroluminescence of LP-MOVPE grown InAs/GaAs quantum dots, and influence of the re-growth temperature on the spectral response

593

1.3 μm InAs quantum dot resonant cavity light emitting diodes

594

1.3 μm range effectively cylindrical In0.53Ga0.47As/In0.52Al0.48As quantum wires grown on (2 2 1)A InP substrates by molecular beam epitaxy

595

1.3 kg bolometers to search for rare events

596

1.3 kg bolometers to search for rare events

597

1.3-(mu)m continuously tunable distributed feedback laser with constant power output based on GaInNAs-GaAs

598

1.3-(mu)m GaInNAs surface-normal devices

599

1.3. Changes in motor cortex and spinal excitability following pedunculopontine nucleus stimulation in humans

600

1.3–0.9 Ga Oaxaquia (Mexico): Remnant of an arc/backarc on the northern margin of Amazonia

601

1.33 mW, 2 V CMOS continuous-time bandpass filter with two decades of centre frequency tuning range and high Q

602

1.34 μm fluorescence and laser properties of Nd:La0.11Y0.89VO4 crystal

603

1.4 Development of postural adjustments during infancy:Evidence for a major transition at 6 months?

604

1.4 μm emission properties and local environments of Tm3+ ions in tellurite glass modified with MoO3

605

1.4. Brain stem control of gait and balance

606

1.5 Early development of postural adjustments in standingwith and without support

607

1.5 V 1.8 GHz bandpass amplifier

608

1.5 V large-driving class-AB buffer amplifier with quiescent current control

609

1.5 V tunable Square-Root Domain filter

610

1.5 μm emission from InAs quantum dots with InGaAsSb strain-reducing layer grown on GaAs substrates

611

1.5 kWe HT-PEFC stack with composite MEA for CHP application

612

1.5 μm Emission and infrared-to-visible frequency upconversion in Er+3/Yb+3-doped phosphoniobate glasses

613

1.5. Contribution of subcortical motor tracts to voluntary movements

614

1.50 (mu)m CW operation of GaInNAs/GaAs laser diodes grown by MOCVD

615

1.5–2.5 nm RTP gate oxides: process feasibility, properties and limitations

616

1.53 μm electroluminescence from ErF3-doped organic light-emitting diodes

617

1.53 μm photoluminescence from ORMOSIL films doped with erbium complexes

618

1.54 and 1.75 μm infrared luminescence of Y2O3:Er3+

619

1.54 μm emission mechanism of Er-doped zinc oxide thin films

620

1.54 μm room temperature emission from Er-doped Si nanocrystals deposited by ECR-PECVD

621

1.54 μm luminescence of Er-doped SiOx and GeOx thin films: A comparative study

622

1.55 $mu$m InAs/InAlGaAs Quantum Dot DFB Lasers

623

1.55 (mu)m bottom-emitting InAlGaAs VCSELs with Al/sub 2/O/sub 3//a-Si thin-film pairs as top mirror

624

1.55 (mu)m monolithic GaInNAs semiconductor saturable absorber

625

1.55 μm emission and upconversion luminescence of Er3+-doped strontium borate glasses

626

1.55 μm InGaAsP/InP tapered stripe superluminescent diodes with potential optical sensor system applications

627

1.55 μm emission and upconversion properties of Er3+-doped oxyflurotellurite glasses

628

1.55-(mu)m spot-size converter integrated laser diode with conventional buried-heterostructure laser process

629

1.55-μm InGaAs/InGaAlAs MQW vertical-cavity surface-emitting lasers with InGaAlAs/InP distributed Bragg reflectors

630

1.57 Ga protolith age of the Neoproterozoic Forquilha eclogites, Borborema Province, NE-Brazil, constrained by U–Pb, Hf and Nd isotopes

631

1.5-Dimensional volatility basis set approach for modeling organic aerosol in CAMx and CMAQ

632

1.5-nm gate oxide CMOS on [110] surface-oriented Si substrate

633

1.5-V CMOS CCII+ with high current-driving capability

634

1.5-V MOS translinear loops with improved dynamic range and their applications to current-mode signal processing

635

1.6 Å Crystal Structure of the Secreted Chorismate Mutase from Mycobacterium tuberculosis: Novel Fold Topology Revealed

636

1.6 GHz space VLBI observation of 3C446 Original Research Article

637

1.6 The early development of walking with and withoutshoes

638

1.6 W of TEM00 cw output at 1.06 μm from Nd:CNGG laser end-pumped by a fiber-coupled diode laser array

639

1.6. Dysarthria due to ischemic brainstem lesions

640

1.6-Tb/s (160*10.7 Gb/s) transmission over 4000 km of nonzero dispersion fiber at 25-GHz channel spacing

641

1.7 Effect of multiple exposures to optical visual flow in infants

642

1.7 kV NPTV-groove clustered IGBT

643

1.7 Volt, DC to 15 GHz Differential Amplifier with Constant Group Delay in InP-HBT Technology

644

1.7. The effect of prepulse stimulation on the post-inhibition EMG rebound following the cutaneous silent period

645

1.76 Ga volcano-plutonism in the southwestern Amazonian craton, Aripuanã-MT, Brazil: tectono-stratigraphic implications from SHRIMP U–Pb zircon data and rock geochemistry

646

1.7MW Nd:YAG Laser Pulse Generation by A Passive BDN Q-switch

647

1.8 Ga iron-mineralized microbiota from the Gunflint Iron Formation, Ontario, Canada: implications for Mars Original Research Article

648

1.8 Ga magmatism in the Fennoscandian Shield; lateral variations in subcontinental mantle enrichment

649

1.8 ka old glass from the Roman ship Julia Felix: glass–water oxygen isotope exchange

650

1.8 Sensory integration and postural control duringontogenesis

651

1.8 billion years of fluid–crust interaction: A zircon oxygen isotope record for the lower crust, western Churchill Province, Canadian Shield

652

1.8. Sound-evoked p11/n15 and p16/n21 responses in human masseter muscles originate, respectively, in activation of vestibular and cochlear receptors

653

1.88–1.87 Ga post-kinematic intrusions of the Central Finland Granitoid Complex: a shift from C-type to A-type magmatism during lithospheric convergence

654

1.8-MHz, 48-V Resonant VRM: Analysis, Design, and Performance Evaluation

655

1.8-V flexible supercapacitors with asymmetric configuration based on manganese oxide, carbon nanotubes, and a gel electrolyte

656

1.9 Changes in the equilibrium of the standing on one legat various life stages

657

1.9 μm superficially porous packing material with radially oriented pores and tailored pore size for ultra-fast separation of small molecules and biomolecules

658

1.94–1.93 Ga charnockitic magmatism from the central part of the Guyana Shield, Roraima, Brazil: Single-zircon evaporation data and tectonic implications

659

1.C.1 Induced mutant mouse models of lipoprotein disorders and atherosclerosis

660

1.C.2 Genetic and genomic dissection of lipoprotein(a) in vivo properties

661

1.C.3 Use of transgenic animal models to study enzymes involved in lipoprotein metabolism and atherosclerosis

662

1.C.4 Genetic dissection of high density lipoprotein metabolism

663

1.C.5 Nuclear receptors as regulators of lipid metabolism

664

1.C.6 New genetic aspects of coronary heart disease

665

1.E.1 New approaches to vascular and lipid disorders: From genes to therapy

666

1.P.1 Rapid and reliable determination of serum amyloid A (SAA) — comparison of three tests

667

1.P.10 Hyperimmunization of chow-fed ApoE deficient mice with homologous oxidized low density lipoprotein suppresses early atherogenesis

668

1.P.101 Heart ultrastructural-functional state in experimental atherosclerosis

669

1.P.109 Vascular function in resistance arteries in JCR:LA-cp rats: A model of insulin resistance

670

1.P.11 Elucidating the role of the putative “apolipoprotein E-like” domain of chicken apolipoprotein A-I

671

1.P.111 The relationships between serum lipids metabolism and ACE activity in normolipidemic and cholesterol-fed rabbits

672

1.P.116 Somatic gene transfer of human apo A-I inhibits atherosclerosis progression in mouse models

673

1.P.119 Nitric oxide synthase gene transfer improves cholesterol-induced vasomotor dysfunction in the rabbit aorta

674

1.P.12 Hydrophobic residues between aminoacids 211–229 of apoA-I play an important role in binding to lipids and lipoproteins

675

1.P.120 In vivo transfer of LDL receptor gene for the treatment of familial hypercholesterolemia

676

1.P.124 The role of variation in the lipoprotein lipase (LpL) gene in the development of type III hyperlipoproteinamia

677

1.P.127 Clinical evaluation of severe hypertriglyceridemia

678

1.P.129 Apo E phenotype and plasma concentration of apo E and Lp E: B particles in patients with mixed hyperlipoproteinemia

679

1.P.13 Displacement of apo A-I by apo A-II results in a decrease of the LCAT activity and promotes the formation of pre-β HDL

680

1.P.131 The occurrence of small dense low density lipoprotein particles in familial combined hyperlipidemia

681

1.P.137 Duslipidemias have a detrimental effect on left ventricular systolic function in patients with acute myocardial infarction

682

1.P.138 Cerivastatin - multicentre, double-blind comparison with placebo and simvastatin in primary hypercholesterolaemia

683

1.P.14 Studies on cDNA sequences of tree shrew apolipoprotein AI and CI

684

1.P.142 Primary prevention in patients with non-insulin dependent diabetes mellitus (NIDDM) and albuminuria: AIDA study (“Atorvastatin in diabetes with albuminuria”)

685

1.P.146 Cholesterol reduction with pravastatin in CARE patients is beneficial irrespective of fasting glucose levels

686

1.P.15 Distinct apo B-100 conformation and surface charge are major determinants of the elevated atherogenicity of small-dense low density lipoprotein particles

687

1.P.150 Basal non-cholesterol sterols reveal a subgroup of 4S not benefitted by simvastatin-induced decrease of recurrent coronary events

688

1.P.152 The effect of combined lipid-lowering and antioxidant therapy on endothelium-dependent vasodilation of the brachial artery in patients with hypercholesterolemia

689

1.P.153 Influence of pravatatin and plasma lipids on clinical events, in the West of Scotland Coronary Prevention Study (WOSCOPS)

690

1.P.157 Multifactorial influence on lipid abnormalities correction in patients after myocardial infarction

691

1.P.16 Enzyme-linked immunosorbent assay for apolipoprotein E in mice serum

692

1.P.160 Serum lipid profile in patients with different clinical stages of squamous cell and small cell lung cancer

693

1.P.162 Follow-up of hypercholesterolaemic patients after participating in a clinical trial

694

1.P.17 Aging decreases rat apolipoprotein AI expression

695

1.P.170 A comparison of clinical and pharmacoeconomic properties of fluvastatin and simvastatin in the management of primary hypercholesterolemia

696

1.P.175 Does diet and exercise in dyslipidemic children lead to a lipid profile similar to that of the athletes?

697

1.P.177 Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia

698

1.P.18 Production of mature apolipoprotein AI in a baculovirus/insect cell system

699

1.P.180 Elimination of different LDL subfractions by LDL apheresis

700

1.P.185 Medium/long-term combined treatment with simvastatin and fenobibrate in high-risk patients with mixed dyslipidemia

701

1.P.190 Efficacy and safety of fluvastatin in patients with hypercholesterolemia: Report of the Turkish multicenter study group

702

1.P.193 Plasma lipoprotein distribution and lipid transfer activities in type IIb hyperlipidemic patients treated with simvastatin

703

1.P.194 Thiazolidinediones exert a hypotriglyceridemic effect by a distinct, but complementary mechanism relative to fibrates

704

1.P.199 The underlying mechanism of the hypolipidemic effect of 3-thia fatty acids

705

1.P.2 Crystallization and preliminary X-ray diffraction data of two different human low density lipoprotein (LDL) subfractions

706

1.P.20 Synthesis and secretion of apolipoprotein B-100 and A-I by chick kidney

707

1.P.204 High density lipoproteins functional properties in patients treated with fluvastatin

708

1.P.206 Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine

709

1.P.209 Lipid lowering effect of FR194738, a novel squalene epoxidase inhibitor, in hamsters and dogs

710

1.P.21 The importance of Lp(a), Lp AI, Apo AI, Apo AII, conventional risk factors on the severity of coronary artery disease (CAD)

711

1.P.211 Patterns of non compliance to cholesterol-lowering therapy assessed by electronic monitoring

712

1.P.217 Effects of fluvastatin alone and in combination with gemfibrozil on lipids and glucose tolerance in resistant hyperlipidaemia

713

1.P.22 Studies on the function domain of apolipoprotein AI

714

1.P.220 Differences in the effect of simvastatin and pravastatin on cholesterol metabolism in patients with hypercholesterolemia

715

1.P.225 Description of a familial hypercholasterolemia kindred protected against atherosclerosis by a genetic form of hyperalphalipoproteinemia

716

1.P.228 Polymorphisms at the 5′-end of the apolipoprotein AI gene and early coronary disease

717

1.P.23 Discovery of Apo AI-LDL and its significance

718

1.P.231 A common Ile405Val mutation in the cholesteryl ester transfer protein (CETP) gene associated with longevity

719

1.P.234 The β3-adrenergic receptor Trp64Arg polymorphism in relation to lipoprotein variation and measures of obesity

720

1.P.24 Apolipoprotein E and beta-A4 amyloid are immunologically and functionally related

721

1.P.240 Familial hypobetalipoproteinemia caused by a truncated apolipoprotein B (B-33.4) is not protective against carotid artery disease

722

1.P.242 Influence of a LDL receptor gene defect on the expression of type III hyperlipoproteinemia

723

1.P.246 New missense and frameshift mutations in the LDL receptor gene causing Japanese familial hypercholesterolemia

724

1.P.247 Apolipoprotein ER112; R251G: A carboxy-terminal variant associated with hyperlipidemia and vascular disease

725

1.P.248 Variety of low-density-lipoprotein-receptor gene mutations and expression of coronary artery disease in heterozygous familial hypercholesterolemia

726

1.P.25 Induction of human apoprotein A-I gene expression in transgenic mice with nephrotic syndrome

727

1.P.252 Characterization of five families with familial defective apolipoprotein B-100 (FDB)

728

1.P.253 Characterization and in vitro expression of a novel apolipoprotein CIII variant identified in individuals of Mayan Indian origin

729

1.P.258 Mutation screening in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay

730

1.P.26 Prevalence of common lipoprotein lipase (LPL) gene mutation Ser447Stop is increased while prevalence of Asn291Ser mutation is decreased in centenarians

731

1.P.262 Characterization of apolipoprotein E3-Nanakuma (Ala214 → Val): An new apolipoprotein E3 variant detected by single strand conformation polymorphism

732

1.P.266 Detection of unknown and recurrent point mutations in hypercholesterolemic patients

733

1.P.267 LPL-93G promoter mutation influences both baseline plasma triglycerides and postprandial response in black and hispanics

734

1.P.268 Variation in the LPL gene is associated with plasma TG concentrations and MI in the European Atherosclerosis Research Study (EARS)

735

1.P.27 Sequence of the rat promoter lipoprotein lipase gene

736

1.P.271 Molecular and clinical characterization of familial hypercholesterolemic heterozygotes in Greece

737

1.P.276 Characterisation of enhancer regions upstream of the apolipoprotein(a) gene

738

1.P.278 Genetic variation in the apolipoprotein CIII gene and effects on plasma triglyceride levels in a large prospective study

739

1.P.28 Binding of apolipoprotein E-containing recombinant chylomicrons to rat liver plasma membranes is stimulated by the monomeric form of hepatic lipase

740

1.P.280 A common substitution lle405Val in the cholesteryl ester transfer protein (CETP) is associated with increased HDL cholesterol and apolipoprotein Al. Studies in a general population sample of 8,989 women and men

741

1.P.284 Absence of a founder effect in familial hypercholesterolemia among sardinians

742

1.P.286 Quantitative genetic analysis of body weight and waist circumference in Japanese American families

743

1.P.289 HDL-cholesterol (HDL-C) of postmenopaused women is influenced by HINC II polimorphism of the LDL receptor (LDL-R) gene

744

1.P.29 Delayed clearance of postprandial chylomicrons in heterozygous lipoprotein lipase deficiency

745

1.P.293 Polymorphisms of the endothelial nitric oxide synthase gene are unrelated to coronary heart disease in the ECTIM study

746

1.P.297 D allele of the angiotensin converting enzyme gene polymorphism increases the susceptibility of young adult smokers to myocardial infarction

747

1.P.3 Insulin decreases serum amyloid A (SAA) secretion from HepG2 cells

748

1.P.30 Inhibition of lipolysis in isolated rat adipocytes

749

1.P.300 Paraoxonase gene isoforms and early carotid atherosclerosis

750

1.P.305 PAI-1 gene polymorphism in patients with premature coronary heart disease

751

1.P.307 Polymorphisms in the human apolipoprotein AIV gene detected by PCR and heteroduplex analysis

752

1.P.308 Age-dependent influence of some genes polymorphisms on predisposition to myocardial infarction in St. Petersburg, Russia

753

1.P.31 Lipoprotein lipase mRNA expression in cultured monocytes isolated from hypertriacylglycerolaemic subjects

754

1.P.312 Homocyst(e)ine level but not MTHFR genotype predicts carotid atherosclerosis

755

1.P.313 Two paraoxonase gene polymorphisms in patients with coronary heart disease

756

1.P.317 Aminoacid dimorphism Gln → Glu at codon 3405 of apolipoprotein B

757

1.P.32 Lipoprotein lipase is needed for the interaction of very low density lipoproteins with heparan sulphate proteoglycans

758

1.P.321 ApoE genotype distribution in a low-cholesterol mediteranean poulation of Southern Italy

759

1.P.322 Multiple cardiovascular risk factors are synergistic in developing progressive coronary atherosclerotic lesions: The Bogalusa Heart Study

760

1.P.328 Is the population distribution of risk factors for coronary heart disease different for men and women?

761

1.P.33 The influence of phospholipids on the size and structure of spherical, reconstituted high density lipoproteins

762

1.P.331 Total cholesterol distributions and time trends in the populations of the WHO-MONICA project

763

1.P.334 The association of apoE phenotype and Lp(a) with cognitive function in Japanese centenarians

764

1.P.339 Are regional differences in coronary mortality in France related to case-fatality or to incidence of events?

765

1.P.34 Use of an intra-venous fat tolerance test to study in vivo the effect of common mutations in the lipoprotein lipase gene

766

1.P.340 Lack of correlation between the prevalence of silent myocardial ischemia and the cardiovascular risk found from the Framingham equation in diabetic patients

767

1.P.341 Haemostatic factors and ischemic heart disease: Siberian monica

768

1.P.346 Peripheral arterial occlusive disease in men: Prevalence and risk factors (preliminary results)

769

1.P.349 LDL oxidation and risk of coronary atherosclerosis

770

1.P.35 Lipoprotein lipase activity in type IV hyperlipoproteinemia with triglycerides above 1.000 mg dl−1

771

1.P.351 Vitamin C deficiency and increased risk of myocardial infarction: Prospective population study in men in Eastern Finland

772

1.P.353 Trends in cardiovascular mortality in a developing country

773

1.P.357 Hemodynamic forces are associated with common carotid wall thickness in healthy subjects

774

1.P.358 Further characterization of triglyceride-rich lipoproteins from patients affected with pseudo-type III dyslipoproteinemia

775

1.P.36 Frequency of lipoprotein lipase gene mutations in subjects with hypertriglyceridemia. Interaction with apo E genotype

776

1.P.362 Soybean isoflavonoids improve systemic arterial compliance

777

1.P.363 Factors affecting spontaneous rupture of the internal elastic lamina in the aorta and iliac arteries of the Brown Norway normotensive rat

778

1.P.366 Vasodilatory response after intravenous L-arginine in the skeletal muscle of patients with premature coronary heart disease

779

1.P.369 The role of arterial mechanics in atherosclerosis

780

1.P.37 Modification of lipoprotein lipase expression in human monocyte-derived macrophages by oxidised forms of low density lipoproteins (LDL)

781

1.P.376 Insulin resistance and ankle on brachial index in hypertensive subjects

782

1.P.377 Evaluation of the angiotensinogen locus in human essential hypertension: An European study

783

1.P.38 Antibody against human neutral sphingomyelinase abrogates TNF-α induced apoptosis in human leukemic (HL-60) cells

784

1.P.381 Carotid wall thickness and deletion polymorphysm of angiotensin I-converting enzyme gene in patients with hypertension

785

1.P.382 Hypertension and fibrinogen in patients with type 2 (non-insulin dependent) diabetes

786

1.P.386 Lipid postprandial metabolism and blood pressure in males with a paternal history of premature CHD

787

1.P.387 Arterial hypertension and insulino-resistance syndrome: The importance of metabolic origins in idiopathic hypertension. A study concerning 45 cases

788

1.P.39 Proteolytic cleavage of lipoprotein lipase facilitates lipoprotein lipase-mediated binding of low density lipoproteins to J774 macrophages

789

1.P.393 Fluorescent determination of CETP activity in plasma

790

1.P.395 Measurements of VLDL-, IDL-, and LDL-apo B levels by a combination of isopropanol precipitation and mass spectrometry

791

1.P.4 Regulation of apolipoprotein gene expression by the orphan intracellular receptor HNF-4

792

1.P.400 Comparison of new methods for HDL-cholesterol determination with the phosphotungstic acid/MgCl2 precipitation procedure

793

1.P.403 Application of gas chromatography/combustion/isotope ratio mass spectrometry to lipoprotein kinetics with 13C labeled tracers

794

1.P.41 The influence of apolipoprotein composition on hepatic lipase-mediated phospholipid and triacylglycerol hydrolysis in reconstituted high density lipoproteins

795

1.P.44 Point mutations in the genes of lipoprotein lipase, hepatic lipase, and insulin receptor as possible susceptibility alleles in familial combined hyperlipidemia

796

1.P.47 Degradation of pyrene-labeled cholesterol esters by lysosomal lipase in vitro and in vivo. Direct visualization with fluorescence microscopy

797

1.P.49 Direct effects of the Asn291Ser variant of the human lipoprotein lipase on the catabolism of VLDL1 and VLDL2 in vivo

798

1.P.5 Hepatocellular de novo lipogenesis and triacylglycerol lipolysis are linked with synthesis, degradation and VLDL output of apoB48

799

1.P.53 A C → T substitution at the position −480 in the hepatic lipase gene is associated with high serum HDL-cholesterol level in Finns, a risk factor for premature coronary heart disease?

800

1.P.54 Molecular and environmental bases of primary type IV hyperlipoproteinemia: Heterozygous lipoprotein lipase deficiency as a causal genetic disorder

801

1.P.56 Relationship between lipoprotein and hepatic triglyceride lipase masses and the premature atherosclerosis of abdominal aorta

802

1.P.59 Fecal bile acid excretion in patients with coronary atherosclerosis and in matched controls

803

1.P.6 Characterization of monoclonal antibodies to human apolipoprotein A-I

804

1.P.63 Pharmacological effects of lipogelosomes® on lipid metabolism in the rat

805

1.P.64 Increased plasma plant sterol level in Otsuk Long-Evans Tokushima fatty (OLETF) rats with gut hypertrophy

806

1.P.65 Delay of fat absorption in rats receiving red wine

807

1.P.7 Association of the apolipoprotein A-IV codon 360 mutation with Alzheimerʹs disease

808

1.P.70 Dietary supplementation with phytosterols or probucol alters fecal excretion of sterols in apo E-knockout mice

809

1.P.75 Paraoxonase activity in human apolipoprotein A-I transgenic rabbits

810

1.P.77 Correction of hypoalphalipoproteinemia in LDL receptor deficiency by lecithin: cholesterol acyltransferase (LCAT)

811

1.P.78 Role of human apolipoproteins in cell cholesterol efflux: Studies with transgenic mice

812

1.P.8 HDL oxidized by tyrosyl radical enhances cellular cholesterol excretion through formation of a crosslinked apolipoprotein A-I–A-II complex

813

1.P.82 Effect of fat diets on lipoproteins and atherosclerosis in mice expression human apolipoprotein-B100 and CETP

814

1.P.84 Regulated expression of GLUT4 minigene in transgenic mice: Effects of exercise training and high-fat diet

815

1.P.9 Structural aspects of the apolipoprotein CIII

816

1.P.90 Protective effect of human apo AI overexpression on atherogenesis in transgenic rabbit

817

1.P.95 Effects of Δ5-olefinic acids from Pinus pinaster seed oil on lipoprotein metabolism in apoE deficient mice

818

1.P.96 Plasma lipids and atherosclerosis in froxfield mixed hyperlipidaemic (previously St Thomas Hospital) rabbits

819

1.P.99 The expression of apolipoprotein E is decreased in stroke-prone spontaneously hypertensive rats but increased with age

820

1.W01.1 Collagens and atherosclerosis: Collagen-cell interaction

821

1.W01.2 Proteoglycan-lipoprotein interactions

822

1.W01.3 Elastin-laminin receptor in atherogenesis

823

1.W01.4 Elastase and elastase inhibitors and pulmonary and coronary artery disease

824

1.W01.5 Physicochemical interaction between plasma lipoproteins and endothelial cell membrane and vascular matrix proteoglycans

825

1.W02.1 Remodeling rather than neointima formation explains restenosis. Insights from experimental studies in pigs

826

1.W02.2 Platelets and arterial remodelling

827

1.W02.3 Phenotypic modulation of smooth muscle after angioplasty remodeling

828

1.W02.4 Smooth muscle cell differentiation and remodeling

829

1.W02.5 Death properties of plaque smooth muscle cells critical to pathogenesis of atherosclerotic plaque and restenosis

830

1.W03.1 Evolution and progression of atherosclerotic lesions

831

1.W03.2 Histological and biological characteristics of de novo and restenotic human atheromatous plaques

832

1.W03.3 Role of thrombosis and hematoma in atherosclerosis progression

833

1.W04.1 Fetal origins of adult disease

834

1.W04.2 Alcohol and risk of cardiovascular disease

835

1.W04.3 New risk factors in the atherosclerosis risk in communities study

836

1.W04.4 Homocysteinaemia as a risk factor for cardiovascular disease

837

1.W04.5 Lipids and lipoproteins as risk factors for atherosclerosis: New biochemical and genetic markers

838

1.W05.1 Structure and function of alleles of the 3′end VNTR region of human apoB gene

839

1.W05.2 Eurogeneheart. Genetic determinants of coronary artery disease in the European union

840

1.W05.3 Common mutations in the lipoprotein lipase gene influence plasma lipids and prevalence of coronary heart disease

841

1.W05.4 Lessons from molecular defects in secretion, transport and reverse transport of cholesterol

842

1.W05.5 Genetic contorl of Lp(a) concenrations

843

1.W06.1 Endothelial activation in atherogenesis — roles of oxidized low density lipoprotein and lysophosphatidylcholine

844

1.W06.2 Structure and function of macrophage scavenger receptors

845

1.W06.3 In vitro and in vivo lipoprotein oxidation

846

1.W06.4 Macrophages and LDL oxidation

847

1.W06.5 Elevated homocyst(e)ine increases ability of human aortic cells to oxidise LDL

848

1.W07.1 Dietary composition and low density lipoproteins (LDL) modifications

849

1.W07.2 Dietary fatty acids and serum lipoproteins

850

1.W07.3 The effects of the Mediterranean diet on glucose metabolism and insulin sensitivity

851

1.W07.4 Evaluation of the clinical efficacy and potential mechanism of the cholesterol lowering effect of soy protein

852

1.W07.5 Dietary vitamin E and cardiovascular disease

853

1.W08.1 Lp(a) and endothelium: A feedback loop in atherosclerosis

854

1.W08.2 The human very low density lipoprotein receptor mediates the uptake and degradation of lipoprotein Lp(a)

855

1.W08.3 Lp(a) metabolism: From assembly to excretion

856

1.W08.4 Function and evolution of Lp(a)

857

1.W08.5 Formation and degradation of triglyceride rich-lipoprotein [a]

858

1.W09.1 Triglycerides are an independent risk factor for coronary heart disease — A debate

859

1/2, 1/4 and 1/8 BPS equations in SUSY Yang–Mills–Higgs systems: Field theoretical brane configurations Original Research Article

860

1/2+ uudd[`(s)]1/2+uuddsˉ pentaquark and instanton-induced forces

861

1/2-homogeneity in symmetric products

862

1/2-Homogeneity of nth suspensions

863

1/2-Homogeneous continua with cut points

864

1/2-Homogeneous suspensions

865

1/3 Subharmonic resonance of a nonlinear composite laminated cylindrical shell in subsonic air flow

866

1/32° real-time global ocean prediction and value-added over 1/16° resolution

867

1/4 Partial breaking of global supersymmetry and new superparticle actions Original Research Article

868

1/8 Factorial Study of Metal Effects on Acid Neutralization by Cement

869

1/f noise due to temperature fluctuations in heat conduction in bipolar transistors

870

1/f noise due to temperature fluctuations in heat conduction in bipolar transistors

871

1/f electrical noise due to space charge regions

872

1/f filtered chaotic processes

873

1/f fluctuations under acoustic cavitation of liquids

874

1/f Noise analysis of songs in various genre of music

875

1/f Noise and intermittency due to diffusion of point defects in a semiconductor material

876

1/f noise and its unusual high-frequency deactivation at high biasing currents in carbon black polymers with residual 1/fγ (γ = 2.2) noise and a preliminary estimation of the average trap energy

877

1/f noise and mechanisms of the conductivity in carbon nanotube bundles Original Research Article

878

1/f noise and multifractal fluctuations in rat behavior Original Research Article

879

1/f noise and self-organized criticality in crisis regimes of heat and mass transfer

880

1/f Noise decomposition in random telegraph signals using the wavelet transform

881

1/f noise in a cellular automaton model for traffic flow with open boundaries and additional connection sites

882

1/f Noise in a nonequilibrium phase transition: Experiment and mathematical model

883

1/f Noise in Carbon Nanotube Devices—On the Impact of Contacts and Device Geometry

884

1/f Noise in dye-sensitized solar cells and NIR photon detectors

885

1/f noise in homogeneous and inhomogeneous media

886

1/f noise in hydrogenated amorphous silicon-germanium alloys

887

1/f noise in polyaniline/polyurethane (PANI/PU) blends

888

1/f noise in Si and Si/sub 0.7/Ge/sub 0.3/ pMOSFETs

889

1/f noise in Si/sub 0.8/Ge/sub 0.2/ pMOSFETs under Fowler-Nordheim stress

890

1/ƒ noise in the distribution of prime numbers

891

1/f noise reduction systems for uncooled heterostructure IR photon detectors

892

1/f noise synthesis model in discrete-time for circuit simulation

893

1/f oscillations in a model of moth populations oriented by diffusive pheromones

894

1/f-Noise structures in Pollocksʹs drip paintings

895

1/fα fluctuations in the time dynamics of Mediterranean forest ecosystems by using normalized difference vegetation index satellite data

896

1/fα noise in spectral fluctuations of complex networks

897

1/fβ temporal fluctuation: detecting scale–invariance properties of seismic activity in North China

898

1/mQ corrections in heavy meson decays

899

1/N-Expansion for the Dicke model and the decoherence program

900

1/Q expansion for the energy spectrum of quantum dots

901

1/η expansion for quasistationary states: complex energies and complex angular momenta Original Research Article

902

1/ν velocity distribution of colliding particles in one-dimensional space

903

1: Procalcitonin in Emergency Department Patients with Suspected Community-Acquired Pneumonia: Results From the GenIMS (Genetic and Inflammatory Markers of Sepsis) Study

904

1: Recombinant Activated Factor VII (rFVIIa) Upon Arrival in the Emergency Department in the Severely Injured Trauma Patient

905

1: Subduction, slab detachment and mineralization: The Neogene in the Apuseni Mountains and Carpathians

906

1:−3 resonant centers on with homogeneous cubic nonlinearities

907

1:1 @ Carleton University School of Architecture

908

1:1 Complexes of octafluoronaphthalene with trans-stilbene and trans-azobenzene

909

1:1 Mode locking and generalized synchronization in mechanical oscillators

910

1:2 Dimethyl-substituted tetracyanoquinodimethane.: Its radical anion mixed salts: ferromagnetic behavior and high electrical conductivity at room temperature

911

1:2 TCNQ/TCNQ−. mixed salts exhibiting ferromagnetic behavior at room temperature

912

1:30000 cryogenic current comparator with optimum SQUID readout

913

1-[(Anthracen-9-yl)carbonyl]-2,7-dimethoxynaphthalene: a chain-like structure composed of face-to-face type dimeric molecular aggregates

914

1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase

915

1-[2-(Diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs

916

1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists

917

1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents

918

1-[2-Hydroxy-3-octadecan-1′-oate]propyl-2″,2″,5″,5″-tetramethyl Pyrolidine-N-oxyl-3″-carboxylate as a potential spin probe for membrane structure studies Original Research Article

919

1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of bloo

920

1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors

921

1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: A novel series of highly potent revertants of P-glycoprotein associated multidrug resistance

922

1-[ω-(4-Arylpiperazin-1-yl)alkyl]-3-diphenylmethylene-2,5-pyrrolidinediones as 5-HT1A receptor ligands: Study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity

923

1`Survey of Health Literacy during pregnancy and Its Relationship with Prenatal Care

924

1′-Carbopalladated-4-ferrocenyl-1,3-oxazolines as catalysts for Heck reactions: Further evidence in support of the Pd(0)/Pd(II) mechanism

925

1′S-1′-Acetoxychavicol acetate as a new type inhibitor of interferon-β production in lipopolysaccharide-activated mouse peritoneal macrophages Original Research Article

926

1′-Trimethylsilylethynyl-, 1′-ethenyl- and 1′-formyl-1-ethynylferrocenes: syntheses and electrochemical properties

927

1+1 string with quarks at the ends revisited

928

1+3 Covariant Cosmic Microwave Background Anisotropies I: Algebraic Relations for Mode and Multipole Expansions

929

1+3 Covariant Cosmic Microwave Background Anisotropies II: The Almost-Friedmann–Lemaître Model

930

1→2 Migration and concurrent glycosidation of phenyl 1-thio-α-mannopyranosides via 2,3-O-cyclic dioxonium intermediates

931

10 - Panic disorder and the outcome of chest pain patients with and without coronary artery disease. a nine-year follow-up study

932

10 Chondromalacia of the humeral trochlea: Description of a new chondral lesion with biomechanical correlation

933

10 Comparison with subacromial bursa and intraarticural synovium associated with rotator cuff tear

934

10 Effects of orthotic devices on gait in individuals with compromised-knee function

935

10 Gb/s * 2 ch signal unrepeated transmission over 100 km of data rate enhanced time-spread/wavelength-hopping OCDM using 2.5-Gb/s-FBG en/decoder

936

10 Gb/s Linear Full-Rate CMOS Phase Detector for Clock Data Recovery Circuit

937

10 Gbit/s optical wavelength converter with a Brillouin scattering-based spectral filter

938

10 Gbit/s series-connected voltage-balancing pulse driver with high-speed input buffer

939

10 Gbit/s small form factor optical transceiver for 40 km WDM transmission

940

10 Gbit/s tunable dual-wavelength nonreturn-to-zero-to-return-to-zero data-format transformer based on a non-direct-current-biased Fabry-Perot laser diode

941

10 GHz, 1 ps regeneratively modelocked fibre laser incorporating highly nonlinear and dispersive photonic crystal fibre for intracavity nonlinear pulse compression

942

10 Hygiea: ISO Infrared Observations

943

10 km Minimum throw along the West Bohemian shear zone: Evidence for dramatic crustal thickening and high topography in the Bohemian Massif (European Variscides)

944

10 million unknowns: is it that big? [computational electromagnetics]

945

10 Molecular mechanisms of reverse cholesterol transport

946

10 Non-surgical synovectomy

947

10 Points in Dimension 4 not Projectively Equivalent to the Vertices of a Convex Polytope

948

10 Prospective confirmation of a biochemical response index

949

10 qualities of an FACC

950

10 Residue Folded Peptide Designed by Segment Statistics

951

10 Years after NNIS; the Use of Comparative Data as a Catalyst for Organizational Improvement

952

10 Years after the crisis: Thailandʹs financial system reform

953

10 years Ecological Indicators!

954

10 years of Current Opinion in Plant Biology 1998 2007

955

10 years of engineering and physics achievements by the Large Helical Device project

956

10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the Heart: From the Methodological Origin to Clinical Practice

957

10 Years of LAGEOS-1 and 15 years of LAGEOS-2 spin period determination from SLR data Original Research Article

958

10 Years of our experience in metabolic bone puncture biopsy

959

10 years of the chair in safety science at the delft university of technology

960

10 years of the International Journal of Information Science and Management: A scientometric and social network analysis study

961

10 years on—the invisible Berlin wall remains

962

10 μA Quiescent Current Opamp Design for LCD Driver ICs

963

10% drop in global industrial output

964

10% from renewables? The potential contribution from an HK schools PV installation programme

965

10 000 years of interannual sedimentation recorded in the Lake Nautajärvi (Finland) clastic–organic varves

966

10 MeV Au ion irradiation effects in an MgO–HfO2 ceramic–ceramic (CERCER) composite

967

10 MVA thyristor converters for the active damping of generator shaft oscillations at ASDEX Upgrade

968

10 years of MS instrumental developments – Impact on LC–MS/MS in clinical chemistry

969

10-(2-Biotinyloxyethyl)-9-acridone: A novel fluorescent label for (strept)avidin–biotin based assays

970

10-(3′-Nitro-4′-pyridyl)-1,8-diazaphenothiazine as the double Smiles rearrangement product

971

10,000 aircraft engines equipped by Techspace Aero

972

10,000 Years of explosive eruptions of Merapi Volcano, Central Java: archaeological and modern implications

973

10. Chromosomal analysis of proliferative and malignant breast disease by chromosome in situ hybridization

974

10. From insidersʹ perspectives: Adjusting to caregiving for patients with LVADs

975

10. HDL subclasses impact of metabolic and therapeutic interventions

976

10. Heart failure education: a catalyst for transitional care

977

10. Improving pain management in hospitalized heart failure patients

978

10. Plasticity induction of the human motor cortex by repetitive quadripulse stimulation at I-wave periodicity

979

10. Quality assurance of tissue and serum markers

980

10. Quality of life of patients with a left ventricular assist device: Implications for a palliative care approach

981

10. Recognizing a mother’s voice in the persistent vegetative state

982

10. Sensory neuropathy, autoimmune peripheral nerve hyperexcitability: A novel mix

983

10. THE INFLUENCE OF EUROPEAN UNION LEGISLATION ON LABOUR MARKET EQUALITY FOR WOMEN

984

10.10 An animal model of locomotor rehabilitation

985

10.11 The relation between motor deficit and proprioceptiveloss after large-fibre sensory neuropathy

986

10.12 Role of ascending propriospinal circuitryin interlimb coordination during mammalian quadrupedal locomotion

987

10.13 Postural control in rabbits: Impairment and recovery after spinal cord lesions

988

10.14 Locomotor-like activity in acute spinalized rats induced by epidural spinal cord stimulation

989

10.15 Stepping movements induced by epidural spinalcord stimulation in decerebrated and spinalized cats in different conditions of afferent control

990

10.16 Participation of the neostriatal cholinergic systemin automation of motor skill in dogs

991

10.17 Feedback regulation of temporal muscle activationpatterns for postural control before and after peripheral neuropathy

992

10.18 Influences of bipedal walking on neuronal systems(using rat bipedal-walking model: RBM)

993

10.19 Kinematic and electromyographic studies of the rat bipedal-walking model (RBM)

994

10.2 Long term motor and cognitives consequences of combined mptp + 3-nitropropionic (3-np) administration in mice: Relevance for striatonigral degeneration (SDN)

995

10.20 Locomotor discoordination in cerebellar Golgicell-deficient mice

996

10.3 Developmental emergence of limb-based locomotor circuitry from an axial-based precursor during amphibian metamorphosis

997

10.4 Reflex pathways to ankle extensors followingstep-training in spinal cats

998

10.5 Neural organization and plasticity of locomotor control in the rhesus monkey

999

10.6 Significance of paw and joint receptors of ankle in formation of locomotor pattern induced by epidural spinal cord stimulation in decerebrated cat

1000

10.6 μm Infrared light photoinduced insulator-to-metal transition in vanadium dioxide

بازگشت